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SUMMARY 
The mature central nervous system (CNS) is unable to fully repair after 
traumatic brain injury (TBI). Following an injury to the adult brain there is a complex 
sequence of events that take place across a broad time course. The cellular 
mechanisms evoked by the brain when attempting to respond to injury need to be 
fully elucidated in order to devise effective therapeutic interventions. The current 
thesis is based upon the hypotheses that recovery following trauma will require the 
activation of reactive and compensatory plasticity and that the mechanisms 
underlying this plasticity are intrinsically different for excitatory and inhibitory cortical 
networks.  
This thesis investigated the reactive and regenerative alterations associated 
with the neuronal response to structural injury. Studies focused on the potential for 
plasticity following injury, specifically comparing the post-injury characteristics of 
excitatory and inhibitory neurons. It demonstrated that the neuronal response to 
injury was subclass specific given that structural injury in vitro induced an axonal 
regenerative response in excitatory neurons and significant dendritic remodeling in a 
subpopulation of interneurons. Additionally, results from functional studies indicated 
that these two mechanisms could both be contributing to the development of post-
injury hyperexcitability.  
This thesis further investigated the interneuron response to injury using a 
clinically relevant in vivo model of diffuse and focal injury, the lateral fluid percussion 
injury model. Immunohistochemistry confirmed that interneurons were not lost after 
mild injury but, consistent with in vitro data, underwent subpopulation specific 
morphological alterations. Furthermore, electrophysiological studies in vivo 
demonstrated changes in inhibitory transmission that could lead to overall changes in 
excitatory/inhibitory balance as demonstrated in in vitro studies. 
Finally this thesis investigated a potential drug treatment for traumatic injury. 
Neuronal cytoskeletal alterations, in particular the loss and misalignment of 
microtubules, are considered a hallmark feature of the degeneration that occurs after 
TBI. Therefore, microtubule-stabilizing drugs are attractive as potential therapeutics 
for use following TBI. This thesis characterized the effect of the brain penetrant 
microtubule-stabilizing agent Epothilone D (Epo D) on post-injury axonal sprouting in 
an in vitro model of CNS trauma. Epo D was found to modulate axonal sprout 
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number in a dose dependent manner, increasing the number of axonal sprouts 
generated post-injury. Specific effects on excitatory neurons were also found. This 
thesis demonstrated that Epo D significantly increases the neuronal regenerative 
response following structural injury.   
In summary this thesis demonstrated intrinsic differences in how excitatory 
neurons and inhibitory interneurons respond to injury. Moreover, it established a 
possible link between this differential response and alterations in excitatory/inhibitory 
balance in the cortex after injury. Furthermore, it identified a possible therapeutic 
intervention for enhancing regeneration following CNS trauma.  
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1. INTRODUCTION 
 
Traumatic brain injury (TBI) is defined as an injury to the brain that is the 
consequence of an external mechanical force and alters normal cognitive, physical 
and/or emotional functioning (Fortune and Wen, 1999, Blennow et al., 2012, Sullivan 
et al., 2016). Epidemiological studies indicate that the worldwide incidence of TBI has 
risen in recent years (Rusnak, 2013, Dewan et al., 2016). This is principally due to 
the increased number of motor vehicle accidents in low to middle income countries, 
the increased incidence of falls among the elderly in high income countries and the 
global increase of military-related traumatic injuries (Langlois et al., 2006, Maas et 
al., 2008, McKee at al., 2014). According to the ‘Centre for Disease Control and 
Prevention’ in the US there are around 1.7 million people that sustain a TBI in that 
country each year, mainly young adults, and this results in approximately 52,000 
deaths per year (Malpass, 2013). The high incidence of TBI among young people is 
particularly devastating as it frequently results in prolonged or life-long motor and/or 
cognitive impairments and places a complex socio-economic and medical burden 
upon society (Roozenbeek et al., 2013). In Australia the most common causes of TBI 
include motor vehicle accidents, falls, injuries derived from violence and sport-related 
injuries. In accordance with the last report of ‘The Victorian Neurotrauma Initiative’ 
the current cost burden of new cases of TBI in the country is estimated to be around 
8.6 billion dollars per year (The Victorian Neurotrauma Initiative, 2010-2011).  
Even though TBI continues to be a leading cause of death and disability 
worldwide, the cellular mechanisms that underpin the central nervous system (CNS) 
degeneration and its inability to induce cellular regeneration after injury are not yet 
understood. As a result it is not surprising that there are no therapeutic interventions 
that can minimize or reverse the primary damage and prevent the complex 
secondary pathologies that develop following injury to the adult brain (Bruns and 
Hauser, 2003). Consequently, determining the basis for the inability of the mature 
CNS to regenerate after injury, documenting the specific functional alterations in the 
injured brain, and identifying therapeutic targets for the development of appropriate 
interventions for the treatment of TBI remain important and relevant avenues for 
research.  
The heterogeneity of TBI is still considered one of the major barriers to finding 
effective therapeutic interventions. However, significant headway has been made in 
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recent years with regards to characterizing the types of injury and trying to link 
specific patterns of damage to appropriate therapies.  
1.1. CLASSIFICATION AND TYPES OF BRAIN INJURY  
 
There are two distinct categories of injuries that can lead to TBI; contact and 
non-contact injuries (reviewed in Finnie, 2002). Contact injuries are a consequence 
of a direct impact to the head and can be further classified as penetrative or not 
penetrative, according to the presence or absence of scalp laceration or skull 
fracture. Non-contact injuries are not penetrative and are produced as a result of an 
abrupt acceleration or deceleration of the head that results in a rotation of the brain 
within the skull (Davis, 2000, Werner and Engelhard, 2007). Both contact and non-
contact injuries can result in focal or diffuse damage to the brain (Povlishock and 
Katz, 2005). Focal damage is usually the result of haemorrhagic lesions within the 
gray matter, or at the gray-white matter interface which usually induce ischemia and 
neuronal death by necrosis or apoptosis (Raghupathi, 2004). Diffuse injuries usually 
occur as a consequence of the differential movement of the brain and the cranium, 
and produce widespread brain dysfunction with little or no macroscopic damage but 
important microscopic axonal changes (DeKosky et al., 2013). These changes are 
usually characterized by the presence of swellings or varicosities along the length of 
axons and the presence of large terminal bulbs known as retraction bulbs 
(Povlishock and Christman, 1995, Smith et al., 2003a, Johnson et al., 2013, reviewed 
in Siedler et al., 2014).  
The brain damage observed after a TBI can be further classified as primary or 
secondary damage. Primary damage involves any damage to the brain that is the 
direct result of an initial injury and occurs within seconds to minutes. The alterations 
produced by the primary damage can be observed at a macroscopic or a cellular level 
and include neural disruptions, shearing of white matter tracts, focal contusions, 
haematomas and diffuse swelling (Maas et al., 2008). Primary injuries often trigger a 
series of secondary injury mechanisms. Secondary injuries involve a complex 
sequence of events across a broad time course and influence different regions of the 
brain. They consist of secondary cellular processes and biochemical cascades that 
are developed over hours, days or even weeks after the initial trauma and 
dramatically worsen the damage caused by the primary injury (Graham et al., 2000). 
These secondary injury processes include: ischemia caused by decreased cerebral 
blood flow; brain swelling; excitotoxicity due to release of excitatory neurotransmitters; 
free-radical generation; calcium-mediated damage, oedema and mitochondrial 
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dysfunction that generates energy failure (Gupta and Przekwas, 2013) (Fig 1.1).  
Furthermore, there is the initiation of necrotic and apoptotic neuronal cell death 
cascades that result in neuronal degeneration and finally denervation (Maas et al., 
2008, Buki and Povlishock, 2006, Saatman et al., 2008). Brain oedema in particular is 
a common consequence of TBI and the its development is one of the most significant 
predictors of outcome after brain injury (Donkin and Vink, 2010). There are two main 
types of oedema, cytotoxic and vasogenic brain edema. Cytotoxic edema is related 
with a failure in ATP-dependent Na+/K+-pumps during energy shortage, increase in 
water content within the intracellular compartment as a result of an osmotic gradient 
and cell swelling. Vasogenic edema occurs when the blood–brain barrier (BBB) 
becomes leaky allowing an influx of plasma from the vasculature into the extracellular 
space (Borgnia et al., 1999, Unterberg et al., 2004, Michinaga et al., 2015). 
 
In a clinical setting traumatic brain injuries can be further classificed according 
to clinicopathological parameters in a severity spectrum as mild, moderate and 
severe injuries. The severity of a brain injury is usually evaluated using the 15 point 
Glasgow Coma Scale (GCS), which takes into consideration 3 major parameters: 
verbal, motor, and eye-opening reactions to stimuli.  In mild TBI, the GCS score is 
≥13, in moderate TBI it is 9–12, and in severe TBI it is ≤8. Importantly, the same injury 
severity may present different pathological and clinical outcomes due to the 
complexity of secondary injury mechanisms that are activated after injury (Fig 1.1) 
(Pitkanen and Immonen, 2014).  
 
 After an injury to the brain, the cortex is particularly susceptible even after a 
mild impact due to its complex and highly organized structure.  
   
1.2. THE NEOCORTEX 
 
 The mammalian cerebrum is comprised of two hemispheres that are ‘coated’ 
by the neocortex. The neocortex is a thin, extended sheet of tissue that contains up 
to 28x109 neurons in humans and approximately 5x106 neurons in mice and is 
responsible for higher order brain functions (Kaas, 1993, Mountcastle, 1997). The 
mammalian neocortex consists of two neuronal types, broadly categorized based on 
morphology: pyramidal neurons or principal cells, and non-pyramidal neurons or 
interneurons (Parnavelas, 2000, Molnar and Cheung, 2006). The structure of the 
neocortex in humans and mice  is relatively uniform consisting of six horizontal layers 
segregated principally by neuronal cell type, size and density, denoted layer I 
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Figure 1.1. Primary and secondary injury mechanisms.  
Schematic representation of post-injury mechanisms activated after an initial 
traumatic injury to the brain.   
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through VI from the most superficial to deep layer (Fig 1.2). The molecular layer, 
layer I, is a relatively cell free layer. Layers II and IV, the external and internal 
granular layers are comprised of relatively small locally projecting interneurons. 
Layers III and V contain characteristic large cortical pyramidal neurons and are 
designated the external and internal pyramidal layers, respectively (Douglas and 
Martin, 2004). Interactions between cortical pyramidal neurons and interneurons 
facilitate highly integrated cortical processing and underlie all coordinated neuronal 
activity (Lehmann et al., 2012, Kubota, 2014). 
1.2.1. Corticogenesis 
 
The development of the cortex, termed corticogenesis, is a highly dynamic 
and complex process involving tightly regulated patterns of neuronal proliferation and 
migration. Neurons destined to form the neocortex are generated at the rostra-dorsal 
region of the neural tube, the telencephalic pallium (Parnavelas, 2002, Noctor et al., 
2004). The two distinct groups of neurons in the neocortex, glutamatergic pyramidal 
neurons and GABAergic interneurons, originate from different regions of the 
telencephalon (Anderson et al., 1997, Anderson et al., 2002). Pyramidal neurons are 
generated in the germinal ventricular zone of the dorsal telencephalon.  Interneurons, 
on the other hand, are generated from neural stem cells located in the ventricular 
zones of the medial ganglionic eminence (MGE), lateral ganglionic eminence (LGE), 
and caudal ganglionic eminence (CGE) of the ventral telencephalon (Parnavelas, 
2000, Wichterle et al., 2001, Nery et al., 2002, Parnavelas, 2002, Rudy et al., 2011, 
Welagen and Anderson, 2011). Pyramidal neurons and interneurons also differ in the 
mode of migration that new neurons use to reach their destination in the cerebral 
cortex. Cells destined to become pyramidal neurons use radial migration, guided by 
radial glia, whereas interneuron precursors use tangential migration to reach the 
developing cortex (Mountcastle, 1997, Nadarajah et al., 2003, Kriegstein and Noctor, 
2004). 
 A number of studies have demostrated that different areas within the ventral 
telencephalon are involved in the generation of specific interneuron subpopulations. 
It has been suggested that the distinct origins of cortical interneuron subtypes may 
account for their heterogeneity in the cortex (Anderson et al., 2001, Anderson et al., 
2002, Fogarty et al., 2007, Kepecs and Fishell, 2014).  
The MGE is the principal source of cortical interneurons in rodents during early 
stages of telencephalic development (E11.5-E14.5) and is the origin of parvalbumin 
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(PV) and somatostatin (SOM)-expressing interneurons (Wichterle et al., 2001, Xu et 
al., 2003, Xu et al., 2004, Butt et al., 2005, Miyoshi et al., 2007). After the MGE, the 
CGE is the next most significant sorce of cortical interneurons, producing around 15-
30 percent of all interneurons (Lee et al., 2010, Miyoshi et al., 2010). The CGE 
produces mainly bipolar Calretinin (CR) expressing interneurons but mostly during 
later stages of neurogenesis (E14.5-E16.5). It also produces vasoactive intestinal 
peptide (VIP) and neuropeptide Y (NPY)-expressing cells (Xu et al., 2004, Welagen 
and Anderson, 2011). The CGE is continuous with, and shares many molecular 
properties with, the LGE, which gives rise to a small fraction of cortical interneurons 
that do not include SOM- or PV-expressing cells (Ma et al., 2012). 
Another area that generates cortical and hippocampal interneurons is the 
embrionic preoptic area (POA). This area gives rise to a relatively homogenous 
population of neurons found in the superficial layers of the cortex that exhibit a 
complex, multipolar morphology. Most neurons arising from the POA are NPY 
positive and SOM negative (Gelman et al., 2009).  
1.2.2. Neocortical neurons  
 
1.2.2.1. Pyramidal neurons 
Pyramidal neurons are the primary glutamatergic excitatory cells of the neocortex 
(Elston, 2003, Fishell and Hanashima, 2008). They have large cell bodies, ranging 
from 10-50 µm in diameter, one long projecting axon and extensive dendritic 
arborisations that have specialized synaptic protrusions termed dendritic spines 
(Garcia-Lopez et al., 2006). They constitute around 60 to 70 percent of the neurons 
in the cortex, and represent a morphologically homogeneous population despite 
having variable synaptic connections and physiological characteristics related to their 
intrinsic membrane properties (Zhang, 2004). Differences in the type and distribution 
of ion channels correlates with differences in membrane properties, the shape of 
action potentials, and the way in which they transform synaptic input into spike 
output. Pyramidal neurons can therefore be classified by their response to current 
injections, as regular spiking neurons and burst neurons. Most pyramidal neurons in 
layers II-VI respond to sustained depolarization by producing a train of action 
potentials at a regular frequency that exhibit spike-frequency adaptation 
(accommodation). By contrast, pyramidal neurons in layer V respond to sustained 
depolarization by firing one or more bursts of action potentials, and have been 
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Figure 1.2. Layers in the cerebral cortex. 
Representation of the six layers of the cortex. The name of each layer reflects the 
cell types that predominantly populate that layer (Adapted from Nolte, 2009). 
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classified as weak or strong bursting depending on the number of spikes they 
generate (Williams and Stuart, 1999).  
Pyramidal neurons have been further classified according to their projection 
targets as Intratelencephalic type (IT type) that project within the telencephalon or 
Pyramidal type (PT-type) that project beyond the telencephalon. It has been 
described that PT-type cells have narrower action potentials with more rapid 
repolarization, whereas IT-type cells have broader action potentials with slower 
repolarization (Suter et al. 2013; Shepherd, 2013, Guan et al. 2015). Furthermore in 
the last couple of years evidence has emerged indicating that genetically-defined 
subpopulations of neocortical pyramidal neurons (etv1 and glt)  also differ in action 
potential properties (Pathak et al. 2016, Cembrowski et al, 2016).  
1.2.2.2. Interneurons 
Interneurons are a group of non-spiny or sparsely spiny neurons that are the 
major source of inhibition in the neocortex. Their axons are restricted to the same 
anatomical region as their cell bodies and dendrites (Letinic et al., 2002), and  they 
comprise around 20-30 percent of all neurons in the neocortex (Defelipe, 2002). 
Interneurons release gamma-Aminobutyric acid (GABA) as a neurotransmitter and 
have been functionally implicated in the regulation of synaptic integration, the 
probability and temporal dynamics of action potential generation and the plasticity of 
pyramidal cells (Huang et al., 2007, Kepecs and Fishell, 2014).  
Unlike the more homogenous pyramidal populations, interneurons are very 
diverse in their morphology and functionality in terms of their intrinsic membrane 
properties, connectivity and dynamics of input and output synapses (Buzsaki et al., 
2004, Caputi et al., 2013) (Fig 1.3). Their complexity and diversity has made it 
difficult to achieve a systematic method of sub-type classification (DeFelipe et al., 
2013). Currently the methods used for classifying inhibitory interneurons are based 
on morphological features in combination with neurochemical and 
electrophysiological characteristic (reviewed in (Druga, 2009). The expression of the 
calcium-binding proteins PV, CR and calbindin-D28K (CB) has been used widely and 
has proven instrumental in categorizing subtypes of interneurons. According to the 
synaptic connections they make with pyramidal cells they can be classified as soma 
and proximal dendrite targeting cells, dendrite targeting cells, axon targeting cells 
and dendrite and tuft targeting cells. (Buzsaki et al., 2004).  
 
	   9	  
Soma and proximal dendrite targeting interneurons 
Soma and proximal dendrite targeting inhibitory interneurons can be further 
classified as large-, small- and nest-basket cells according to their axonal and 
dendritic morphology, expression of calcium binding proteins and neuropeptides 
(Wang et al., 2002). Basket cells are the most common type of interneuron in the 
neocortex representing around 50% of all inhibitory cells. They target the soma and 
proximal dendrites of pyramidal cells (Freund, 2003, Druga, 2009). Large Basket 
cells have long multipolar dendrites and extensive axonal arborizations. They 
represent the major source of lateral inhibition across columns within the cortical 
layer containing their cell bodies, but also inhibit cells within the upper and lower 
layers. Large basket cells usually express the calcium binding proteins CB and PV 
and the neuropeptides, neuropeptide Y (NPY) and cholecystokinin (CCK) (Rudy et 
al., 2011). They also occasionally express somatostatin (SOM) and CR, but never 
vasoactive intestinal peptide (VIP) (reviewed in Markram et al., 2004, Druga, 2009). 
Small basket cells have dense and very complex axonal arborizations and rarely 
elaborate axons beyond the cortical layer or column in which they reside. Small 
basket cells are usually present as multipolar cells in layer IV and as bitufted or 
bipolar cells in layer II/III. They express the same calcium binding proteins and 
neuropeptides as large basket cells, but they also express VIP (Markram et al., 
2004). Nest basket cells are similar to large and small basket cells, but can be 
identified by their bird’s nest-like morphology and the their lack of CR and VIP 
expression (Wang et al., 2002).  
 
Dendrite targeting interneurons 
The sub-population of interneurons that synapse onto dendrites are 
morphologically and functionally more diverse than any other sub-group, and include 
double bouquet cells, bipolar cells, neurogliaform cells and bitufted cells. Double 
bouquet cells usually have a bitufted dendritic morphology and a characteristic thick 
axon that resembles a horsetail. They are distributed across all layers but are more 
common in supragranular layers (Yanez et al., 2005).Double bouquet cells are a 
source of interlayer, and probably intracolumnal inhibition. They express CR and CB 
and can also express VIP or CCK but not PV, SOM or NPY (Markram et al., 2004, 
Druga, 2009). Bipolar cells are small cells with ovoid soma and narrow bipolar 
dendrites that extend vertically to layer I and down to layer VI (DeFelipe, 1997). They 
are CR positive and can express VIP (Cauli et al., 2014). Neurogliaform cells are 
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small interneurons with a highly branched, dense dendritic field that forms a sphere 
and also elaborates a thin but densely branched axon. A subset of neurogliaform 
cells co-express CB and NPY. Bitufted cells are similar to bipolar and double 
bouquet cells. They usually have an ovoid soma from where two primary dendrites 
project in opposite directions to each other.  They are found in layers II-VI and 
express CB, CR, NPY, VIP, SOM and CCK, but not PV (Druga, 2009). 
 Dendrite and tuft targeting interneurons 
The principal dendrite and tuft targeting interneuron is the Martinotti cell.  
Martinotti cells represent about 15 percent of the total interneuron population.  They 
are found in layers II–VI, and project their axons toward layer I where they inhibit the 
tuft dendrites of pyramidal neurons. Their axons can also project horizontally to 
inhibit cells in other columns, providing cross-columnar inhibition (Wang et al., 2004). 
They have a bitufted morphology with a very elaborate dendritic tree. Martinotti cells 
always express SOM and never express PV or VIP (Defelipe, 2002, Markram et al., 
2004, Druga, 2009).  
Axon targeting interneurons 
Chandelier cells are the only axon targeting interneurons, allowing them to 
override all prior signal integration to modify the action potential output of the 
pyramidal cell (Freund, 2003, Taniguchi et al., 2013). They possess smooth 
dendrites and a unique characteristic axon with terminal boutons that resemble 
candlesticks (DeFelipe, 1999).  The terminal boutons innervate only the initial 
segments of pyramidal cell axons and never innervate other interneurons. Chandelier 
cells are found in layers II–VI of the neocortex, and typically express one or both of 
the calcium-binding proteins PV and CB, but not CR (Inan and Anderson, 2014). 
1.2.2.2.1. Funtional classification of interneurons 
Interneurons possess a wide range of active and passive membrane 
properties and this has allowed researchers to use their response to depolarization 
as a way to characterize or define specific subpopulations. According to their intrinsic 
firing characteristics interneurons can be classiffied as fast spiking (FS) cells, burst- 
spiking non-pyramidal (BSNP) cells, regular-spiking non-pyramidal (RSNP) cells, 
late-spiking (LS) cells and irregular-spiking (IS) cells (Fig 1.4).  
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Figure 1.3. Inhibitory interneurons in the neocortex. 
 
 Schematic representation of the major interneuron subtypes that populate different 
layers of the cortex (Adapted from Raghanti et al 2010). 
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Fast spiking interneurons 
FS interneurons in the cortex are typically PV-expressing basket and chandelier cells 
(Kawaguchi et al., 1987). When depolarized to threshold these cells generate a train 
of action potentials at high frequency, each with a large and fast after 
hyperpolarization. These neurons show little spike frequency adaptation, have a 
lower input resistance than all other subtypes of interneurons, and are generally 
more hyperpolarized at rest (Kawaguchi and Kubota, 1996). Due to their prevalence 
throughout the cortex and the magnitude of their response, FS cells are thought to be 
key regulators of the excitatory-inhibitory balance in the cortex.   
Burst spiking non-pyramidal and regular spiking non-pyramidal interneurons 
The burst spiking non-pyramidal and the regular spiking non-pyramidal firing 
patterns are associated with the Martinotti, double bouquet and bipolar cells. The 
burst spiking non-pyramidal interneurons show a typical burst-like discharge with two 
or more low threshold spikes from hyperpolarized potentials. They represent mainly 
SOM expressing Martinotti cells of layer V that can co-express CB and also VIP 
expressing double bouquet cells in layer II/III and V. SOM- and VIP-expressing burst 
spiking non-pyramidal neurons produce longer duration action potentials, have a 
higher input resistance and a more depolarized resting membrane potential than fast-
spiking interneurons (Kawaguchi and Kubota, 1996, 1997).  
 
The regular spiking non-pyramidal cells discharge in a similar manner to 
regular spiking pyramidal cells. Regular spiking non-pyramidal neurons have been 
recorded in layers II/III and V, and have been identified as SOM-expressing Martinotti 
and VIP-expressing double bouquet and bipolar cells in layers II/III and V 
(Kawaguchi and Kubota, 1996, 1997, 1998). Usually in SOM-expressing regular 
spiking non-pyramidal cells depolarization only induces a depolarizing hump with a 
single spike (Kawaguchi and Kubota, 1996). 
 
Late spiking (LS) cells 
Late-spiking (LS) cells discharge with a considerable delay after a 
depolarizing step near threshold. These cells are found in layers II/III and V, and 
have been identified as neurogliaform cells (Kawaguchi et al., 1987, Gupta et al., 
2000). 
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Figure 1.4. Firing characteristics of inhibitory interneurons in the neocortex. 
 
 Interneuron cell types defined by a combination of marker expression and intrinsic 
firing properties (Adapted from Kepecs and Fishell, 2014) 
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Irregular spiking (IS) cells 
Irregular spiking (IS) cells are the small fraction of vertically oriented bipolar 
interneurons within layers II/III and V that express CR or VIP (Cauli et al., 1997). 
They fire an initial burst of action potentials, between two and six depending on the 
level of depolarization, followed by irregularly spaced action potentials. They have 
the highest input resistance of all interneuron subtypes (Kawaguchi and Kubota, 
1996, Cauli et al., 1997, Vucurovic et al., 2010). 
The diversity of inhibitory interneurons and synapses, as well as a balance 
between excitatory and inhibitory connections, are crucial for normal neocortical 
function. The complexity and specificity of neuronal connections renders the brain 
particularly vulnerable to external insults such as TBI. Post-injury alterations in the 
excitatory and complex inhibitory circuits have not been fully elucidated and need 
further investigation.  
 
1.3. THE NEURONAL RESPONSE TO INJURY  
 
1.3.1. Axonal injury  
 
Axonal injury is a common consequence of TBI.  Pyramidal cell axons are 
particularly vulnerable to injury as they project over long-distances and have a 
complex and highly organized structure (Meythaler et al., 2001, Johnson et al., 
2012). Axonal injury can be a consequence of a primary injury or can occur as a 
secondary effect. Primary axonal injury or primary axotomy is the result of a rapid 
and direct disconnection of the axon into two separate segments at the moment of 
injury (Blennow et al., 2012). Axonal degeneration can also be a consequence of a 
series of events that take place after a primary injury known as secondary axonal 
injury or diffuse axonal injury (DAI). DAI is considered a progressive event, gradually 
evolving from a focal axonal alteration to a delayed axonal disconnection (Buki and 
Povlishock, 2006). Animal and human studies indicate that secondary axotomy is the 
most common form of axotomy after TBI (Povlishock, 1992, Christman et al., 1994).  
DAI is initiated by the disruption of axonal transport that leads to axonal 
swelling and ends with disconnection or secondary axotomy and Wallerian 
degeneration of the distal segment of the axon (Maxwell et al., 1990). The gold 
standard for the pathological identification of DAI is the detection of Amyloid 
Precursor Protein (APP). APP has been observed to accumulate rapidly after an 
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injury forming typical spheroid-shaped APP+ axonal swellings (Gentleman et al., 
1993, Sherriff et al., 1994, Buki and Povlishock, 2006). A recent study indicates that 
a range of different phenotypes of axonal pathologies can be found after axonal 
injury with variable labeling for APP, and some of these morphologies not only 
represent different stages of an evolving pathology, but are related to specific axonal 
compartments and even to different neuronal subtypes (Hanell et al., 2015a). 
Therefore the axonal response to injury requires further investigation as 
understanding this process may enable the development of novel treatments to 
target primary and secondary axon degeneration.  
1.3.1.1. Injury related alterations to the cytoskeleton  
 
The cytoskeleton is the underlying scaffold maintaining neuronal structure. It 
consists of an array of fibrous proteins that are dynamic and enable diverse cellular 
processes such as cell division, intracellular transport and cell migration (Fletcher 
and Mullins, 2010). The axonal cytoskeleton is highly vulnerable to injury, and it is 
now recognized that even in the absence of initial axonal transection, and in 
seemingly mild forms of TBI, adverse alterations occur at the level of the axonal 
cytoskeleton that have disastrous consequences for neuronal function (Smith et al., 
2013). Cytoskeletal alterations such as neurofilament compaction and disruption, and 
the disassembly of microtubules, are thought to lead to defective axonal transport 
and swelling that are characteristic features of DAI (Smith and Meaney, 2000). After 
TBI there can be a disruption to the cell membrane surrounding the axon, which is 
called the axolema, and this disruption leads to Ca++ influx.  Even though the primary 
mechanism leading to extracellular calcium influx is largely understood for large 
caliber axons, in fine caliber, non-myelinated neurons the source of local calcium is 
not related to axolema disruption, but rather to the activation of Na+ channels that 
causes depolarization. This results in Ca++ influx through the activation of voltage-
gated Ca++ channels and reversal of the Na+/Ca++ exchange pumps (Wolf et al., 
2001). Some data also implicate voltage-gated L- and T-type calcium channels and 
the release of Ca++ from intracellular stores in facilitating the post-injury influx of Ca++ 
(Knoferle et al., 2010, Stirling et al., 2014). Regardless of the mechanism, Ca++ influx 
causes axonal damage, destruction of the axonal cytoskeleton, mitochondrial 
dysfunction and ultimately cell death. The intensive sequestration of extracellular 
Ca++ opens the mitochondrial membrane permeability transition (MPT)-pore (Zoratti 
and Szabo, 1995, Kim et al., 2003, Mazzeo et al., 2009). Induction of the MPT-pore 
results in mitochondrial swelling, axon disconnection and finally cell death through 
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the MPT release of pro-apoptotic enzymes such as cytochrome-c and apoptosis 
inducing factor (Cai et al., 1998, Bernardi and Forte, 2007, Lemasters et al., 2009) 
(Halestrap, 2009). Furthermore, mitochondrial dysfunction is related to energy-failure 
and results in dysfunction or failure of ionic pumps that leads to uncontrolled ionic 
homeostasis, further mitochondrial swelling and neuronal death (Liu et al., 2009).  
The axolemal disruption has also been linked to the activation of cysteine 
proteases and the proteolytic degradation of the cytoskeletal network (Buki and 
Povlishock, 2006, Johnson et al., 2012). Two important members of the cysteine 
protease family are the calpains and caspases. Caspases are a well-described group 
of cysteine proteases with a characteristic function in apoptosis.  Calpains, on the 
other hand, are considered to play an important role in necrosis and apoptosis 
(Harwood et al., 2005). The activation of these two groups of proteases worsens 
outcomes after injury as they actively participate in the degradation of the local 
axonal cytoskeleton resulting in local axonal failure and disconnection (Ma, 2013). 
Microtubule disruption following injury can have severe effects on neuronal 
structure and function. The loss and misalignment of microtubules plays an important 
role in degeneration, while preventing regeneration of the injured neuron. In 
particular it is recognized that the post-injury calcium influx affects microtubule 
disassembly and leads to a loss of microtubule associated proteins (MAPs) such as 
tau and MAP-2 (Smith et al., 1999, Smith and Meaney, 2000, Farkas and Povlishock, 
2007, Tang-Schomer et al., 2010).  
The importance of microtubule deregulation in TBI pathology suggests that 
treatment with compounds that stabilize cytoskeletal microtubules after injury can 
potentially modify multiple aspects of the brain’s response to trauma and improve 
outcomes after brain injury (Brunden et al., 2010, Hellal et al., 2011, Sengottuvel et 
al., 2011, Baas and Ahmad, 2013b, Hur et al., 2014). Recent publications have 
presented proof-of-principle experiments indicating that the microtubule-stabilizing 
drug Paclitaxel, widely used for cancer treatment, can enhance axon regeneration, 
improve function and reduce glial scarring after injury (Hellal et al., 2011, Sengottuvel 
et al., 2011). However, a more recent study has found no axon regeneration or 
functional recovery after spinal contusion injury with the use of the same drug 
(Popovich et al., 2014). The discrepancy in these observations reinforces the fact 
that a more comprehensive and mechanistic understanding of the neuronal response 
to injury, and more specifically microtubule dynamics after injury, is needed before 
microtubule-stabilizing drugs can move forward as a realistic post-injury drug 
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treatment.  
Neurofilaments provide tensile strength and establish neuronal structure and 
are also frequently altered by TBI (Hall and Lee, 1995, Posmantur et al., 2000, Smith 
and Meaney, 2000, Siedler et al., 2014). Neurofilament disruption occurs within 
minutes of the injury and can persist for hours, causing impaired axonal transport 
and swelling. Three principal proteins compose the neurofilaments, NF light (NF-L), 
medium (NF-M), and heavy (NF-H) proteins, with NF-M and NF-H including side 
arms of different lengths. These side arms may be phosphorylated and the extent of 
this phosphorylation is related to the diameter of axons (Hisanaga and Hirokawa, 
1990, Hall and Lee, 1995). Neurofilament compaction is often attributed to 
proteolysis of the neurofilament side arms (Povlishock et al., 1997, Okonkwo et al., 
1998). It is hypothesized that this could be the consequence of an imbalance 
between protein kinases and phosphatases, or could result from disrupted calcium 
homeostasis and the abnormal activation of proteolytic calpains that cleave the 
neurofilament side arms (Buki et al., 2003, Ma, 2013). The overall consequence is 
the reduction of intra-filament spacing and neurofilament compaction (Christman et 
al., 1997, Smith et al., 2003, Johnson et al., 2013).  
Another characteristic of neurofilament dysfunction after TBI is their aberrant 
phosphorylation. Neurofilaments are normally maintained in a dephosphorylated form 
in the neuronal cell body and dendrites and are phosphorylated in the axons 
(Maxwell and Graham, 1997). Neurofilament phosporylation regulates axonal 
transport, such that hypophosphorylated neurofilaments are transported more quickly 
than phosphorylated neurofilaments (Shea et al., 2003). After TBI, phosphorylated 
neurofilaments accumulate in the cell body of neurons, which impedes the transport 
of neurofilaments to the axons and decreases axon caliber after TBI (Huh et al., 
2002, Hamberger et al., 2003).   
 
1.3.2. Interneurons and their response to injury 
 
 
Several studies have demonstrated that the adult CNS retains a significant 
capacity for structural plasticity in response to alterations in sensory experience or 
after injury. Neuronal plasticity is defined in terms of alterations in synaptic strength 
and wiring, axonal sprouting, remodeling of dendritic arbors and changes in dendritic 
spine and axonal bouton turnover (Florence, 1998, Grutzendler et al., 2002, Hickmott 
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and Steen, 2005, Holtmaat et al., 2005, Lee et al., 2006, Lee et al., 2008, Campbell 
et al., 2012). Looking specifically at the interneurons and their capacity for dendritic 
arbor remodeling, Lee et al. (2006, 2008) indicated that inhibitory neurons are 
capable of significant dendritic remodeling under normal physiological conditions. 
They demonstrated that in the visual cortex GABA-positive non-pyramidal 
interneurons exhibit dynamic arbor rearrangements while pyramidal cells remain 
stable. These results indicate that dendritic structural remodeling is an example of 
adult plasticity and that circuit rearrangements in the adult cortex are restricted to 
specific cell types (Lee et al., 2006). Further studies proved that the interneurons that 
remodel their dendrites are contained within a dynamic zone corresponding to a 
superficial band of layers II/III. Furthermore, dendritic remodeling is not inherent to a 
specific interneuron subclass, suggesting that the capacity of interneurons to 
rearrange their neurites is not determined by genetic lineage, but rather imposed by 
cortical laminar circuitry (Lee et al., 2008). 
  The dendritic remodeling of interneurons has also been studied under 
pathological conditions. Blizzard et al. (2011) demonstrated that a population of 
interneurons respond to focal structural injury in a manner that is entirely different to 
principal projection neurons. Following a discrete unilateral lesion to the adult rodent 
somatosensory cortex, CR positive interneurons remodeled their dendrites away from 
the injury site, while the regenerative response of pyramidal neurons was the 
opposite, sprouting axons into the site of injury (Blizzard et al., 2011). How other 
subpopulations of interneurons respond to injury, and how this response differs with 
injury type is currently under investigation. Further research is required to gain a 
better understanding of the role of interneurons in modulating degeneration and 
regeneration of the nervous system after TBI. Furthermore, the unique response of 
interneurons to injury could make them novel targets for therapeutic interventions 
aimed at minimizing secondary pathologies.  
 
 1.4. NEURONAL REGENERATION AND REPAIR FOLLOWING TBI  
 
Complete functional recovery after an injury to the adult brain would be 
predicted to require the replacement or repair of dead or damaged cells in the injury 
site and/or the compensatory remodeling of surrounding intact cells to bypass the 
damaged circuitry. The two main mechanisms by which lost neuronal connections 
and degenerated neurons can be replaced are axonal regeneration and 
neurogenesis. Contrary to the common belief that mature neurons are incapable of 
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significant regeneration, a number of studies have demonstrated that damaged 
axons initially react to the injury and undergo regenerative sprouting (King et al., 
2001, Dickson et al., 2007). This indicates that mature neurons have an intrinsic 
capacity to adaptively respond to damage and to attempt regeneration (King et al., 
2000, Chuckowree and Vickers, 2003, Blizzard et al., 2009, Blizzard et al., 2011). It 
remains to be shown, however, that regeneration can be achieved by promoting 
spouting response at or around the injury site or that this response is beneficial and 
promotes functional recovery. There is some evidence indicating that post-injury 
sprouting may not always be functionally appropriate, with potentially aberrant axonal 
connectivity contributing to the development of epilepsy following brain trauma (Salin 
et al., 1995, McKinney et al., 1997). 
In terms of neuron replacement, the adult brain has two major stem cell 
niches, the subventricular zone (SVZ) of the lateral ventricles, and the subgranular 
zone of the dentate gyrus of the hippocampus.  The SVZ in particular is a known site 
of neurogenesis where neural progenitor cells are present and are capable of 
differentiating into neurons, astrocytes and oligodendrocytes (Romanko et al., 2004). 
There is evidence suggesting that after an injury to the brain the rate of cell 
proliferation is altered.  Some studies indicate that this injury-induced cell 
proliferation could result in the generation of new neurons and/or glial cells (Gu et al., 
2000, Magavi et al., 2000, Arlotta et al., 2003, Chen et al., 2003). After TBI the 
potential manipulation of these progenitor cell populations could result in newly 
produced cells that could compensate for the significant neuronal cell loss.  
1.4.1. Axonal regeneration versus axonal sprouting 
 
Axonal regeneration refers to successful restoration of the contact between 
the axotomised neuron and its original neuronal target. For complete regeneration to 
occur there should also be remyelination of the damaged axon, and the 
reestablishment of functional synapses (Horner and Gage, 2000, Tuszynski and 
Steward, 2012). Damaged axons in the adult mammalian peripheral nervous system 
(PNS) and the developing CNS are able to fully regenerate after injury (Ferretti et al., 
2003). The regenerative ability of adult PNS neurons is achieved by the reactivation 
of an embryonic growth program that involves changes in gene expression related to 
a rapid axonal growth that leads to functional regeneration (Smith and Skene, 1997, 
Makwana and Raivich, 2005).   
On the other hand damaged neurons from the adult CNS do not fully 
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regenerate but usually ‘sprout’ after injury. Sprouting describes a process related to 
any outgrowth from cut or intact fibers that spans moderate distances and leads to 
the formation of multiple local axon collaterals that do not usually result in the 
restoration of normal connectivity (Horner and Gage, 2000, Cafferty et al., 2008, 
Tuszynski and Steward, 2012). The inability of the adult mammalian CNS to 
regenerate after injury is related to intrinsic cell-autonomous factors as well as 
extrinsic factors within the environment of the mature brain, such as the presence of 
myelin-associated inhibitors and the formation of the glial scar (Silver and Miller, 
2004, Yiu and He, 2006, Huebner and Strittmatter, 2009).  
1.4.2. Extrinsic barriers to axon regeneration  
 
1.4.2.1. Myelinating cells and myelin-associated inhibitors  
Myelin plays a key role in limiting post-injury axonal outgrowth in the CNS. It 
has been well described that after an injury neurons are exposed to myelin debris, 
which is inhibitory to axonal growth. It is believed that the post-injury regenerative 
abilities of PNS and CNS neurons is at least partially due to the PNS and CNS being 
myelinated by different cell types.  There is evidence that CNS myelin, unlike PNS 
myelin, can be a source of axonal outgrowth inhibition since CNS myelin expresses 
myelin-associated inhibitory factors (Schwab and Thoenen, 1985, Yiu and He, 2006). 
Furthermore, in the PNS there is limited exposure of severed axons to the inhibitory 
myelin environment, as Schwann cells and macrophages rapidly clear myelin debris 
from the injury site (Reichert et al., 1994, Martini et al., 2008). In the CNS there is a 
slower activation and recruitment of macrophages after injury, which is reliant on the 
blood brain barrier (BBB) being compromised, and this could account for the 
differences in the post-injury environment that leads to limited axonal regeneration in 
the CNS (Lotan and Schwartz, 1994, Hirschberg and Schwartz, 1995, Rapalino et 
al., 1998). However, this is controversial as other studies indicate that the number of 
activated macrophages after injury can be similar in the PNS and CNS, and that 
differences in regeneration are mainly related to the myelinating cells themselves 
(Leskovar et al., 2000).  
In this regard, it has been demonstrated that there are intrinsic differences 
between Schwann cells and oligodendrocytes, with respect to their response to injury 
(Filbin, 2003, He and Koprivica, 2004, Yiu and He, 2006). These cells play a key role 
after neuronal injury in creating a growth-promoting environment in the PNS and a 
growth inhibiting environment in the CNS (Allen and Barres, 2009). In the PNS after 
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injury, Schwann cells de-differentiate and down regulate all myelin proteins so that 
they become permissive to axonal regeneration (Filbin, 2003). On the other hand, in 
the CNS, oligodendrocytes do not down regulate myelin proteins but instead 
continue to express them after injury thereby limiting axonal growth (Sivron and 
Schwartz, 1994). Additionally, there is very little death of Schwan cells after axonal 
injury and this allows for an active role of these cells in axonal regeneration forming 
new myelin conduits to guide and nurture regenerating axons (Brosius Lutz and 
Barres, 2014). In the CNS there is widespread loss of oligodendrocytes after injury. 
Moreover, there is evidence suggesting that the remaining uninjured 
oligodendrocytes have very little capacity to promote axonal regeneration and 
remyelination (Keirstead and Blakemore, 1999). Furthermore, oligodendrocytes have 
been linked to growth inhibition following injury due to the release of growth inhibitory 
factors or myelin associated inhibitors.  
There are a number of myelin associated axonal growth inhibitors described 
in the literature but among them the myelin proteins Nogo, myelin associated 
glycoprotein (MAG) and the oligodendrocyte myelin glycoprotein (OMgP) have been 
studied in more detail since they represent the main proteins associated with growth 
inhibition (Brosius Lutz and Barres, 2014). The Nogo inhibitory factor has three 
different isoforms (Nogo-A, -B, and -C). Nogo-A is mainly expressed in the nervous 
system, while Nogo-B and -C are widely expressed outside the CNS (GrandPre et 
al., 2000). Nogo-A is enriched in oligodendrocytes in the endoplasmic reticulum and 
on the cell surface of the myelin sheath (Fujita and Yamashita, 2014). It has a 
pathologic role in limiting axon regeneration post-injury with two domains that are 
inhibitory to axonal growth, Nogo 66 and amino-nogo (Chen et al., 2000, Huber and 
Schwab, 2000, Prinjha et al., 2000, GrandPre et al., 2002). The MAG is a 
transmembrane protein associated with myelin formation and maintenance. MAG 
can promote axonal growth during the neonatal period but becomes inhibitory after 
birth. After axonal injury myelin damage leads to the release of a soluble proteolytic 
form of the protein that inhibits axonal regeneration (Tang et al., 2001, Wong et al., 
2002, Yiu and He, 2006). The oligodendrocyte myelin glycoprotein is a glycosyl 
phosphatidyl-inositol (GPI)-linked protein. It is a relative minor component of myelin 
that is expressed not only by oligodendrocytes but also by neurons. All these myelin 
associated inhibitory factors have been shown to bind to the same Nogo receptor on 
axons and form a complex with the P75 nerve growth factor receptor (NgR-P75) 
(Fournier et al., 2001, Wang et al., 2002a). This complex signals via the small 
intracellular GTPase, RhoA. RhoA activates ROCK and triggers downstream 
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effectors that regulate cytoskeletal reorganization, growth cone collapse and neurite 
outgrowth inhibition (Lehmann et al., 1999, Fujita and Yamashita, 2014). 
1.4.2.2. Glial scar 
Mature astrocytes respond to injury through a complex series of events 
globally referred to as reactive gliosis (Sofroniew, 2005). Reactive astrocytes form a 
glial scar at the lesion site that helps isolate the injury and minimize the area of 
inflammation and cellular degeneration, although it becomes a barrier to axon 
regrowth (Silver and Miller, 2004, Yiu and He, 2006). The glial scar is not only a 
physical barrier for axonal regeneration but also contains molecules that impede 
axon outgrowth. Chondroitin sulfate proteoglycans (CSPGs) are upregulated by 
reactive astrocytes after CNS damage and are both membrane bound and secreted 
into the extracellular space, forming a concentration gradient along the injury 
(Huebner and Strittmatter, 2009). There is a very high concentration of inhibitory 
molecules at the center of the injury site and regenerating axons eventually become 
dystrophic and fail to regenerate near the lesion epicenter as a result of an inhibitory 
and non-growth conducive environment (Toy and Namgung, 2013).  
Many studies in the past have focused largely on characterizing the growth 
inhibitory molecules in the CNS, (Schwab, 1990, Silver and Miller, 2004, Case and 
Tessier-Lavigne, 2005, Yiu and He, 2006, Yamashita and Fujita, 2014) and 
significant effort has been made to block these inhibitory molecules by genetic and 
pharmacological approaches in order to promote axonal growth (David and Aguayo, 
1981, Schnell and Schwab, 1990, Schwab, 1992, Bregman et al., 1995, Bandtlow 
and Schwab, 2000, GrandPre et al., 2002, Tauchi et al., 2012, Carballo-Molina and 
Velasco, 2015). However, blocking these inhibitory molecules only lead to limited 
regeneration, and the majority of the adult neurons still failed to regenerate their 
axons (Schwab, 1992, Kim et al., 2004, Zheng et al., 2005). This supports the idea 
that extrinsic inhibitory factors as well as intrinsic cell-autonomous mechanisms are 
involved in the regenerative failure of injured adult CNS neurons. 
1.4.3. Intrinsic or cell-autonomous axon regeneration mechanisms  
 
In vivo and in vitro data support the concept that neuronal maturation is 
associated with the gradual loss of the intrinsic growth capacity of the neuron 
(Brundin et al., 1988, Wigley and Berry, 1988, Fawcett et al., 1989, Hankin and Lund, 
1990, Shimizu et al., 1990, Liu et al., 2011). The growth-associated protein 43 (GAP-
43), the phosphatase and tensin homolog (PTEN) and the cyclic adenosine 
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monophosphate (cAMP) are among the factors that have emerged as regulators of 
the growth state of embryonic and PNS neurons and have been involved in the lack 
of regeneration of the adult CNS after injury (Tuszynski and Steward, 2012).   GAP-
43 regulates cytoskeletal remodeling in the neuronal growth cone, a process 
fundamental for axon elongation. Its expression is high during development, declines 
through adulthood and increases during regeneration (Jacobson et al., 1986, Stein et 
al., 1988). In the PNS there is a steady increase in the expression of GAP-43 that is 
related to a phase of axonal elongation and regeneration (Yang and Yang, 2012). By 
contrast, in the adult CNS, a weak and transient expression of the protein relates to a 
spontaneous sprouting response that does not usually lead to functional recovery 
(Aigner et al., 1995).  
Another intrinsic factor involved in the regulation of neuronal growth and post-
injury regeneration is PTEN. PTEN is a negative regulator of axon growth that shows 
increased expression in adult neurons and suppresses the activity of the mammalian 
target of rapamycin (mTOR) (Krishnan and Zochodne, 2014).  mTOR is a protein 
kinase that regulates protein translation, cell growth and size (Hay and Sonenberg, 
2004). It has been demonstrated that the deletion of PTEN activity can increase the 
capacity of adult neurons to regenerate their axons after injury (Park et al., 2010, Lee 
et al., 2014). Previous studies have shown that the genetic depletion of PTEN activity 
promotes robust axon regeneration after optic nerve injury in adult retinal ganglion 
cells (RGCs) (Park et al., 2008). Furthermore, studies in injured adult corticospinal 
neurons indicate that PTEN deletion enables the mounting of a robust regenerative 
response after spinal cord injury (Liu et al., 2010). PTEN signaling is also involved in 
oligodendrocyte-axon interactions and is important for myelin integrity.  Even though 
the inhibition or deletion of PTEN has been shown to have beneficial effects on 
neuronal regeneration, the chronic activation of the mTOR pathway in 
oligodendrocytes can have negative consequences for axonal integrity and 
myelination (Harrington et al., 2010).  
The cyclic adenosine monophosphate (cAMP) has also been shown to be a 
growth-promoting factor inducing axonal growth and regeneration. In the PNS after 
neuronal injury there is activation of the membrane-bound adenylyl cyclase that 
converts ATP into the second messenger cyclic AMP (Makwana and Raivich, 2005, 
Navarro et al., 2007). The production of cyclic AMP alters the physiology of the 
neuron, changing its function from one of neurotransmission to one of growth and 
regeneration, activating a series of down-stream effectors (Yaniv et al., 2012, Knott 
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et al., 2014). In the CNS elevated endogenous cAMP, as well as a decrease in its 
degradation, have been shown to induce axonal regeneration after injury (Bhatt et 
al., 2004, Pearse et al., 2004, Lau et al., 2013).  
Overall it is likely that a complete functional recovery following a traumatic 
injury to the adult brain would require the replacement of lost and dying neurons, the 
regeneration of lost axons, and their reconnection to synaptic targets. The plastic 
response of neurons to injury, that determines the brain’s potential for compensation 
and recovery, has not been fully elucidated. Understanding how specific 
subpopulations of neurons respond to injury is crucial in order to try to manipulate the 
injured brain’s potential for plasticity and facilitate desirable outcomes after injury.  
 
1.5. THESIS AIMS  
 
One important factor underlying the lack of effective strategies to treat TBI is 
an incomplete understanding of the fundamental cellular processes activated by an 
injury to the brain. Relatively few studies have directly addressed the role of 
interneurons in the degenerative and regenerative responses evoked by TBI. The 
primary objective of this thesis is to further investigate the unique response of 
subpopulations of neurons to injury in order to gain a better understanding of the 
events that take place after damage to the adult brain and potentially help develop 
effective therapeutic strategies. The current thesis is based upon the hypotheses that 
recovery following trauma will require the activation of reactive and compensatory 
plasticity and that the mechanisms underlying this plasticity are intrinsically different 
for excitatory and inhibitory cortical networks. 
 
Aim 1: To determine if different neuronal subpopulations are selectively 
vulnerable in a model of in vitro axonal injury.  
 
A full understanding of the neuronal response to injury is vital for devising 
successful post-injury treatments. To date, a comprehensive study focusing 
specifically on neuronal subtype specific responses to injury has not been performed. 
Chapter 2 of this thesis aimed to investigate excitatory and inhibitory neuron 
vulnerability to injury using an in vitro model of transection injury, in combination with 
immunocytochemical and electrophysiological techniques.  
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Aim 2: To investigate interneuron responses to injury in a clinically relevant in 
vivo model of focal and diffuse injury.  
 
To date, the literature regarding the susceptibility of interneurons to injury 
remains inconclusive. Given the importance of appropriate interneuron function for 
providing balanced inhibition in the cortex, it is imperative that the extent of 
interneuron damage is evaluated following traumatic injury. In Chapter 3 of this thesis 
a rodent model was utilized to determine the effects of traumatic injury on specific 
subpopulations of interneurons and the induction of post-injury interneuron 
regeneration. Furthermore, post-injury functional studies were performed to 
investigate changes in inhibitory synaptic input. 
 
Aim 3: To use an in vitro platform of injury to test microtubule stabilization as a 
pharmacological intervention for the treatment of TBI. 
 
Microtubule stabilizing drugs, such as epothilones, are now being 
investigated for their potential use in treating diseases of the nervous system.  The 
importance of microtubule dysregulation in TBI pathology suggests that post-injury, 
treatment with compounds that stabilize cytoskeletal microtubules may modify 
multiple aspects of the brain’s response to trauma and improve outcomes after TBI. 
In Chapter 4 the effect of Epothilone D (Epo D) on the post-injury axonal sprouting of 
mature cultured cortical neurons was examined. The response of regenerating axons 
to Epo D treatment was analyzed using immunocytochemistry, live imaging and 
molecular techniques. 
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2. AXONAL TRANSECTION IN MATURE CORTICAL NEURONS INDUCES 
CELL SPECIFIC DENDRITIC REMODELING 	  
2.1 INTRODUCTION 
 
Accumulating evidence indicates that the brain can undergo substantial 
reorganization after injury. The capacity of the brain to adapt after structural injury is 
globally referred to as post-injury plasticity. Plastic changes after injury can include 
alterations in synaptic strength, remodeling of axonal and dendritic arbors and 
neurogenesis (Keyvani and Schallert, 2002, Chuckowree et al., 2004, Carmichael, 
2006, Dancause and Nudo, 2011, Hunt et al., 2011, Canty et al., 2013, Perederiy 
and Westbrook, 2013). The degree of plasticity occurring after injury has been 
classically linked to age, mode of injury, and/or the extent and region of injury 
(Horner and Gage, 2000, Chen et al., 2002, Cafferty et al., 2008). More recent 
studies suggest that post-injury plasticity can also be dependent on the 
subpopulation of neurons affected, specifically in terms of dendritic remodeling 
(Blizzard et al., 2011, Canty et al., 2013), consequently implying that a particular 
response to injury can be intrinsic to a specific neuronal subtype.  These results 
indicate that a broader understanding of the response of different subpopulations of 
neurons to structural injury and the possible mechanisms underlying these 
responses is needed.  
 
Dendrites are the structures responsible for receiving and processing neuronal 
inputs. Their morphology, in terms of branching pattern, determines the number and 
type of inputs a neuron can receive (Macias, 2008). During early postnatal 
development neuronal dendritic branching patterns can be significantly remodeled 
and shaped by experience and learning during critical periods (Bavelier et al., 2010). 
There is extensive evidence indicating that inhibitory interneurons play a crucial role 
in neuronal plasticity as an increase in cortical inhibition regulates the onset and 
closure of critical periods (Hensch, 2005, Di Cristo et al., 2007, Baroncelli et al., 
2011, Chen et al., 2011). However, in adulthood most dendritic arbors remain 
virtually stable in the naïve brain. This has been described in a number of relevant 
imaging studies where no dendritic arbor structural changes were found in pyramidal 
neurons in any region of the cortex (Trachtenberg et al., 2002, Mizrahi and Katz, 
2003). In contrast to excitatory pyramidal neurons, non-pyramidal inhibitory 
interneurons seem to be more plastic and exhibit a range of dendritic structural 
modifications when imaged over time in the primary visual cortex (Lee et al., 2006, 
Lee et al., 2008) and other regions of the cortex (Chen et al., 2011). While the role of 
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inhibition during development is increasingly well understood, recent studies have 
indicated that changes in the inhibitory circuitry are also involved in regulating 
dendritic plasticity in adulthood. Furthermore, it has been suggested that 
morphological modifications in inhibitory cell axons and dendrites after sensory 
deprivation can precede and drive the changes observed in the excitatory circuitry 
(Yazaki-Sugiyama et al., 2009, Marik et al., 2010, Keck et al., 2011, Chen and 
Nedivi, 2013). 
 
Given the important part that interneurons play during developmental plastic 
periods and their involvement in plasticity after sensory deprivation, the aim of this 
Chapter was to gain insights into the possible role of inhibitory neurons in plastic 
changes after traumatic injury. To facilitate the investigation of the differential 
response of excitatory and inhibitory neurons to structural injury an in vitro model of 
injury was developed. Post-injury plasticity was explored in terms of morphological 
changes in the dendritic arbor, focusing specifically on a subpopulation of Calretenin 
expressing interneurons.  The Calretinin population of interneurons was selected for 
this study as they have the capacity to remodel their processes after injury (Blizzard 
et al., 2011). In the current investigation, modifications in their dendritic arbor were 
investigated in detail at different time points post-injury, at increasing distances from 
the injury site, and were compared with changes in other populations of interneurons 
and also pyramidal cells.  
 
The in vitro model of axonal injury was used to investigate the intrinsic response 
of excitatory and inhibitory neurons to structural injury. Primary cortical neuronal 
cultures have been extensively used for the study of neurotransmission, 
neurodegeneration, and neurodevelopment (Morrison et al., 2011, Gordon et al., 
2013). Despite being widely utilized, a comprehensive analysis of the functional 
development of different populations of neurons and the electrophysiological 
characteristics of excitatory and inhibitory neurons in culture had not been 
undertaken. In the current study, the electrophysiological characterization of neurons 
in vitro allowed the evaluation of not only morphological subpopulation-specific post-
injury alterations, but also important insight into functional changes. 
 
 
 
	   28	  
2.2. MATERIALS AND METHODS 
 
2.2.1.  Wild type and transgenic mice 
All experimental procedures involving animals were approved by the Animal 
Ethics Committee for animal experimentation of the University of Tasmania 
(A0011952) and were performed in accordance with the Australian Code of Practice 
for the Care and Use of Animals for Scientific Purposes. Thy1-YFP transgenic mice 
(B6; CBA-Tg Thy1-YFP GJrs / GfngJ) were obtained from the Jackson Laboratory 
(Bar Harbor, ME). GAD67-GFP mice were developed by Prof. Nobuaki Tamamaki 
(Kyoto University) and were a kind donation from Prof. John Bekkers (Australian 
National University). GAD67-GFP mice are on a C57BL6/J background and express 
green fluorescent protein (GFP) in neurons expressing GAD67, one of the two genes 
that encode isoforms of the GABA-synthesizing enzyme, glutamic acid 
decarboxylase (Tamamaki et al., 2003, Suzuki and Bekkers, 2010). Animals were 
bred at the University of Tasmania. Animals were housed in individually ventilated 
cages, maintained at ~20oC, on a 12 hour light/dark cycle, with access to food and 
water ad libitum.  
2.2.2. Cell culture 
Primary dissociated cortical neuron cultures were prepared from mouse 
embryos as previously described (Dickson et al., 2000). Briefly, Thy1-YFP and 
GAD67-GFP transgenic mice were time-mated, the pregnant females killed by CO2 
exposure at 15.5 days of gestation, and the embryos removed.  Embryos were 
genotyped by fluorescence imaging using 470nm light on a Carestream Image 
station 4000MM pro (Carestream Molecular Imaging, USA).  Neocortical 
hemispheres were dissected into 5ml Hanks Buffered Salt Solution (HBSS; Thermo-
fisher Scientific, USA).  Cortical tissue was dissociated by enzymatic digestion 
(0.025% w/v Trypsin, 5 minutes, 370C), which was halted by the addition of 1ml of 
pre-warmed medium [NeurobasalTM supplemented with 2% v/v B27, 10% v/v fetal 
calf serum, 0.5mM L-glutamine, 25µM glutamate and 1% streptomycin penicillin; 
Thermo-fisher Scientific, USA]. Tissue pieces were allowed to settle and after 
removal of the medium, dissociation was completed by resuspension of the cells in 
500µl of pre-warmed medium and gentle trituration.  Cell viability and concentration 
was assessed using trypan blue vital dye exclusion.  3.5 x 104 cells/mm2 were plated 
per 19mm diameter glass coverslip (Marienfeld, Germany).  Each coverslip was pre-
coated with 0.001% Poly-L-lysine (Sigma-Aldrich, USA) in 0.01M PBS (pH 7.0). 
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Cultures were maintained in a 37°C humidified atmosphere of 5% CO2 for up to 15 
days.  At 1 day in vitro (DIV) the medium was removed and replaced with serum-free 
growth medium [NeurobasalTM, 2% v/v B-27 supplement, 0.5mM L-glutamine, and 
1% streptomycin penicillin; Thermo-fisher Scientific, USA], after which time ~50% of 
the medium was replaced every 3–4 days. 
2.2.3. Electrophysiology 
Cortical neurons cultured on glass coverslips for 7 DIV or 15 DIV, were 
superfused with bicarbonate-buffered solution [155mM NaCl, 3.5mM KCl, 1mM 
NaH2PO4, 26.2mM NaHCO3, 1.4mM MgCl2, 2.4mM CaCl2, and 11mM glucose; 
osmolarity adjusted to 295-305mOsm/kg by the addition of D-sorbitol (all Sigma)].  A 
single cell expressing GFP or YFP was whole-cell voltage-clamped and was filled 
with Alexa Fluor-568 dye.  Electrophysiological data for analysis were obtained from 
neurons (at room temperature) that had a resting membrane potential (RMP) below -
40mV. Voltage-gated sodium and potassium currents were elicited with a series of 
voltage steps (from -70 to 50mV, in 10mV increments) from a holding potential of -
70mV.  The peak net inward current (reflecting the difference between the inward INa 
and the other voltage-dependent outward currents) was quantified after subtracting 
the capacity current and an assumed ohmic leak current, scaled from the response 
to hyperpolarizing pulses (as per (Clarke et al., 2012).  Voltage responses to current 
injection were recorded from the cell’s resting potential (applying 25pA steps for 
200ms from -100 to 500pA).  After recording, the patch electrode was removed from 
the cell, where possible leaving the soma intact for imaging.  
 
Patch electrodes formed from borosilicate glass capillaries (1.5mm O.D. x 
0.86mm I.D, Harvard Apparatus, UK) with a resistance of 5-7MΩ were filled with a 
solution containing: 130mM K-gluconate, 4mM NaCl, 10mM HEPES, 0.5mM CaCl2, 
10mM BAPTA, MgATP 4mM, Na2GTP 0.5mM, pH set to 7.4 with KOH, and 
osmolarity adjusted to 290mOsm/kg with D-sorbitol. An Axopatch 200B amplifier 
(Molecular Devices, USA) was used for voltage- and current-clamp. Data were 
adjusted to account for the electrode-junction potential.  Data were sampled at 10 
kHz and filtered at 5 kHz using pClamp 9.2 software, and offline analysis was 
performed using Igor (WaveMetrics) and Axograph scientific software.  
2.2.4. Axonal transection  
Axonal transection was carried out using a Barkan goniotomy knife (Kaisers, 
Germany) on cortical cultures at 15 DIV (Blizzard et al., 2013). A single injury 
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extending the full diameter of the coverslip was made, ensuring complete axonal 
transection and producing a cell free lesion of ~50-150µm wide. Cells were fixed for 
30 minutes with 4% (w/v) paraformaldehyde (PFA) in 0.01M phosphate buffered 
saline (PBS) at 0, 4 and 24 hours post-injury for immunocytochemistry. Sprouting 
response observed in cortical culture in vitro has been demonstrated to start between 
3 to 6 hours post-injury (Chuckowree and Vickers, 2003). Therefore the imaging time 
point of 4 hours post-injury was chosen in order to match the initial sprouting 
response of the transected axons. The 24 hours post-injury time point was chosen to 
match the continued sprouting response. For electrophysiological studies coverslips 
were transported to the electrophysiology rig covered in culture media.  
2.2.5. Immunocytochemistry 
Primary antibodies used included rat monoclonal anti-green fluorescent 
protein to detect YFP or GFP (1:3,000; Nacalai tesque), rabbit anti-Calretinin 
(1:1000; Swant) and rabbit anti-activated caspase 3 (1:200, Millipore) diluted in 0.3% 
v/v triton-X100 (Fluka) in PBS, and applied for 1 hour at room temperature followed 
by overnight incubation at 4°C.  Coverslips were washed thrice in PBS before the 
application of isotype- and species-specific secondary antibodies. Secondary 
antibodies [Alexa Fluor® 594- and AlexaFluor® 488-conjugated goat anti-rat and 
goat anti-rabbit IgG H+L (Invitrogen, USA)] were diluted 1:1000 in PBS and applied 
to coverslips for 2 hours at room temperature.  Coverslips were washed thrice with 
PBS before mounting in fluorescent mounting medium (Thermo Fisher scientific, 
Australia).  
 
Immunolabeling was visualized and imaged using a DMLB2 upright 
fluorescent microscope (Leica, Germany). For cell counts of uninjured cultures four 
images were taken from different regions in each coverslip. Every time point was 
examined in four replicate coverslips across three independent experiments. For cell 
counts of injured cultures and remodeling analysis, images were taken across the 
length of the scratch injury at increasing distances from the injury site (0-500µm from 
the injury, 500-1000µm from the injury site and more that 1000µm from the injury) in 
order to investigate distance specific effects after injury. These distances were 
chosen due to technical reasons representing one or two whole rotations on the X 
plane using a 20X magnification in a DMLB2 upright fluorescent microscope (Leica, 
Germany). Approximately ten images were taken from each of four replicate 
coverslips across three independent experiments. To further characterize the 
populations of Thy1-YPF neurons, Calretinin interneurons and GAD67-GFP 
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interneurons after injury, the cell tracing software NeurolucidaTM was utilized. Each 
neuron was further assessed with Neurolucida Explorer to determine the dendritic 
angle by performing the segment dendrite analysis (Fig 2.1). For caspase 
immunolabeling a minimum of four images were taken from two coverslips that 
contained the injury site at every time point analyzed (0, 4 and 24 hours post-injury). 
 
2.2.6. Statistical analysis 
Analysis of post-injury remodeling was done using a two-way analysis of 
variance followed by Bonferroni post hoc tests (GraphPad Prism, version 6.0). 
Average values were expressed as means ± standard error of the mean. For 
electrophysiological comparisons of multiple groups a one-way analysis of variance 
followed by Bonferroni post hoc tests was used. For comparisons between 2 groups  
two-tailed t-tests were performed (GraphPad Prism, version 6.0). A p-value <0.05 
was considered significant. 
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Figure 2.1 Analysis of post-injury neurite remodeling in vitro.  
 
Representative Neurolucida tracing of CR immunolabelled cell (A) and its XY angle 
analysis using Neurolucida Explorer (B). Neurites were classified according to the 
angle they form with the injury site as projecting “away” from the injury site if they 
form an angle of 0 to 180 degrees with the injury site or “towards” the injury site if the 
form an angle of 180 to 360 degrees with the injury site (C).  
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2.3. RESULTS 
 
2.3.1. Mouse cortical interneurons become functionally mature by 15 DIV 
 
 
The electrophysiological characteristics of GFP+ interneurons derived from 
GAD67-GFP transgenic mice, was performed at 7 and 15 DIV. The 
electrophysiological properties of these cultures were examined to determine the 
time required for interneurons to mature in vitro they had matured and express a 
sufficient density of voltage-gated channels to fire action potentials. Interneurons at 7 
or 15 DIV were targeted for whole cell patch clamp recording, and were concurrently 
filled with Alexa Fluor-568 dye (Fig 2.2 A-D). Passive membrane parameters were 
first examined. Interneurons were classified according to their morphology in vitro as 
multipolar and bipolar. 7 DIV GFP+ multipolar neurons had a mean resting membrane 
potential (RMP) of ~-59mV (n=7 cells), an input resistance of ~408MΩ, a capacitance 
of ~25.1pF, and a peak inward current of ~-2.01nA. By 15 DIV they became 
significantly hyperpolarized  (~-69mV, p<0.01, n=11 cells) (Fig 2.2 E), their input 
resistance decreased from ~408MΩ to ~178MΩ (Fig 2.2 F) and their capacitance 
increased from ~25.1pF to ~37pF (Fig 2.2 G). These data indicated that by 15 DIV 
multipolar interneurons have increased in size and complexity and have begun to 
express significantly more ion channels at the membrane surface, potentially 
contributing to the observed reduction in RMP. Importantly, the peak inward current 
for these neurons increased from -2.01±0.4nA to -2.98±0.86nA from 7 to 15 DIV (Fig 
2.2 H).  Although the capacitance and INa had both increased with time in culture, 
these data revealed an overall increase in voltage-gated sodium channel density 
from 68±12 to 94±22pA/pF, which suggests that the neurons were more likely to fire 
action potentials.  
 
The active membrane parameters of interneurons were also analyzed using 
current clamp. The presence of evoked action potentials in response to current 
injections has been previously reported to correlate with cell maturity (Picken Bahrey 
and Moody, 2003). Multipolar interneurons at 7 DIV failed to generate action 
potentials in response to step-wise current injections. Interneurons that had been 
cultured for 15 days responded to current injections by generating a train of action 
potentials. All multipolar interneurons fired action potentials when exposed to 
depolarizing current injections (Fig 2.2 M, N).  
At 7 DIV GAD67-GFP+ bipolar interneurons (n=5) had an average RMP of  
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~-46mV, an input resistance of ~965MΩ, a capacitance of ~13.5pF and a small 
inward current of ~-0.58nA (Fig 2.2 I-L). There was a significant decrease in their 
RMP by 15 DIV (n=20) to ~-55mV (p<0.01). But no significant changes in other 
passive membrane parameters indicating that these cells had not grown in size or 
complexity, or increased their voltage-gated sodium channel density during their 
second week in vitro.  Although this may indicate that GFP+ bipolar interneurons are 
not mature at 15 DIV, approximately 60 per cent of the neurons were able to fire 
action potentials. This increase in action potential frequency could likely be 
accounted for by their significant hyperpolarization and the slight increase in their 
peak inward current (n.s, p=0.243) by 15 DIV (Fig 2.2 M, N). 
Action potential characteristics were further analyzed and compared between 
populations of bipolar and multipolar interneurons. Action potential amplitude and 
duration were used to compare the functional maturity of subpopulations of 
interneurons in culture at 15 DIV (Fig 2.3 A). As these properties were reported to 
reflect the maturity of neurons in culture (Johnson et al., 2007). There was no 
significant difference in action potential amplitude (p=0.457) or duration (half width) 
(p=0.713) between the populations of bipolar and multipolar interneurons at 15 DIV 
(Fig 2.3 B, C). These results suggest that, although not all bipolar interneurons were 
able to fire action potentials in response to depolarizing current injections, the ones 
that did exhibited the firing characteristics of mature neurons.  
Collectively these results indicate that cortical interneurons derived from 
GAD67-GFP mice grown in vitro become functionally mature by 15 DIV.  
2.3.2. Mouse cortical pyramidal neurons become functionally mature by 15 
DIV 
The electrophysiological properties of Thy1-YFP cultures were examined to 
determine whether they had matured and expressed a sufficient density of voltage-
gated sodium channels to fire action potentials in vitro.  YFP-positive neurons that 
were 7 or 15 DIV were used to make whole cell patch clamp recordings, and were 
concurrently filled with Alexa Fluor-568 dye (Fig 2.4 A-H).  It was determined that 
YFP+ neurons at 7 DIV had a mean resting membrane potential (RMP) of ~-65mV 
(n=8 cells; Fig 2.4 I), an input resistance of ~320MΩ (Fig 2.4 J), a capacitance of 
~30pF (Fig 2.4 K), and a small peak inward current at 0mV of ~-1.7nA (Fig 2.4 D, L).  
At 15 DIV the RMP of the cultured neurons was unchanged (n=5 cells; Fig 2.4 I).  
However, their input resistance was reduced (Fig 2.4 J), and their capacitance 
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increased (Fig 2.4 K) consistent with neurons that have been maintained in culture 
for longer and have grown in size and complexity.  Importantly, the peak inward 
current for neurons measured at 0mV was significantly increased from -1.7±0.3nA to 
-2.9±0.5nA from 7 to 15 DIV (Fig 2.4 D, H, I).  Although the capacitance and INa had 
both increased with time in culture, these data still revealed an overall increase in 
voltage-gated sodium channel density from 57±9 to 72±13pA/pF, which suggested 
that the neurons were more likely to fire action potentials by 15 DIV.   
Cortical neurons in primary culture have been reported to mature over time 
and elicit action potential firing patterns consistent with those described for neuronal 
populations in cortical slices (Mainen and Sejnowski, 1996). As the density of voltage 
gated sodium channels calculated above can only be used to estimate a neurons 
ability to fire an action potential, the firing pattern of Thy1-YFP labeled neurons in 
vitro was investigated using current clamp.  At 7 DIV, neurons failed to generate an 
action potential in response to step-wise current injections (5 of 8 neurons did not fire 
an action potential, and 3 of 8 neurons fire 1 or 2 action potentials in a 200 
milliseconds current step; Fig 2.4 M). Neurons that had been cultured for 15 days 
responded to current injection by generating a train of action potentials (all neurons 
examined fired in the range of 5-8 action potentials during the 200 milliseconds 
current injection step; Fig 2.4 N).  These data indicate that cortical neurons cultured 
for 15 DIV better represent mature neurons in vivo than those cultured for 7 DIV. 
2.3.3. Interneurons grown in vitro maintain subclass diversity   
 
In cultures derived from GAD67-GFP mice GABAergic interneuron subtypes 
are labeled with GFP.  In cultures derived from Thy1-YFP mice pyramidal neurons 
are labeled with YFP. By performing whole cell patch clamp recordings of GFP+ and 
YFP+ cells at 15 DIV the membrane properties of interneurons and pyramidal 
neurons were compared. During patching all neurons were filled with the Alexa Fluor-
568 dye present in the internal solution, revealing their morphology (Fig 2.5 A-F). 
Interneurons were classified as Bipolar if they had two principal long dendrites 
running in opposite directions from the soma with few dendritic collaterals. 
Interneurons were classified as Multipolar if they present more than two dendrites 
emerging from the soma.  
 
 Significant differences were found in all the passive membrane parameters 
analyzed between the populations of multipolar and bipolar interneurons, indicating 
that they truly represent different and independent populations of interneurons (Fig 
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2.5 G-J). 
There were also significant differences found in all passive membrane 
parameters in pyramidal neurons in comparison to bipolar interneurons (Fig 2.5 G-J). 
There were no significant differences found when comparing multipolar interneurons 
and pyramidal neurons at 15 DIV. 
 
The electrophysiological analysis revealed at least 4 different firing patterns in 
response to depolarizing current injections in GFP+ interneurons. Different firing 
patterns were recorded from the group of multipolar interneurons indicating that 
distinct subpopulations might be present (Fig 2.5 K-M). A more detailed analysis of 
each interneuron subclass within the multipolar group based on current clamp 
characteristics was attempted but was not achieved due to a limited number of 
recordings form interneurons in each subgroup. Only one firing pattern was recorded 
for bipolar interneurons (Fig 2.5 N).  
 
These data indicate that the fundamental properties of a neuron, such as 
membrane potential, action potential characteristics, and ionic currents, are likely 
intrinsically regulated, are specific to each population of neuron and are conserved in 
vitro. These results validate the use of primary neuronal cultures as a relevant 
platform to investigate the response to injury of interneurons and pyramidal neurons. 
The in vitro axonal transection injury model was used in this chapter to investigate 
subpopulation specific post-injury alterations.  
 
2.3.4. Calretinin interneurons remodel their neurites after injury   
 
Neurons derived from Thy1-YFP transgenic mice were grown for 15 DIV, 
subjected to axonal transection and fixed at 0, 4 and 24 hours post-injury. 
Immunolabeling with antibodies to both the calcium binding protein Calretinin and 
YFP were used to identify Calretinin interneurons and pyramidal neurons 
respectively. Neurites labeled with Calretinin or YFP were traced using NeurolucidaTM 
and a X-Y dendritic angle analysis was performed (Fig 2.6 A, B). They were then 
classified as being directed either “away” from the injury site if they formed an angle 
of 0 to 180 degrees with the injury site or “towards” the injury site if they formed an 
angle of 180 to 360 degrees with the injury site (Fig 2.6 C).  
 
To quantitate injury-induced changes in the dendritic arbor orientation, Calretinin or 
YFP positive neurons were traced at increasing distances from the injury site and at 
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different time points post-injury (Fig 2.6 A-D). The orientation of individual neurites for 
each neuron was determined and the percentage of neurites that were orientated 
away or towards the injury site was calculated.   
 
At 4 hours post-injury, for neurons located more than 500µm from the injury 
site, there were no significant difference in the percentages of Calretinin or YFP 
positive neurites that were directed away from the injury site (Fig 2.6 E, F). Further 
analysis indicated that for neurons located closer to the site of transection (less than 
500µm) there was a significant increase in the number of Calretinin positive neurites 
directed away from the injury (Fig 2.6 G). The same analysis was performed at 0 and 
24 hours post-injury and no significant differences were found between the two 
populations of neurons investigated (Fig 2.6 H, I).  
 
To gain further insight into subpopulation specific post-injury responses, 
cultures derived from GAD67-GFP mice were grown to maturity in vitro and exposed 
to axonal injury. Neurons were fixed at 4 hours post-injury and interneurons that were 
either GAD67-GFP+ or CR+/GAD67-GFP+ were investigated for their capacity to 
remodel after injury. Results indicate that only CR+/ GAD67-GFP+ interneurons are 
able to remodel their neurites away from the injury site at 4 hours post-injury at a 
close distance from the injury site (Fig 2.7 A, B, p=0.005).  
 
In order to investigate the intrinsic functional implications of remodeling in the 
subpopulation of CR+ GAD67-GFP+ interneurons after injury, patch clamp recordings 
interneurons that usually express Calretinin was attempted. All patched bipolar 
GAD67-GFP+ interneurons (at 4 hours post-injury and found at less than 500µm from 
the injury site) had a depolarized RMP (less than -40mV) after injury and could not 
be used for analysis.  
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Figure 2.2. Development of GAD67-GFP positive interneurons in vitro.  
 
Phase image of GAD67-GFP positive bipolar (A) and multipolar interneurons 
selected for whole cell patch clamp analysis at 7 DIV (C). Bipolar (B) and multipolar 
(D) neurons filled with Alexa Fluor-568 dye. Passive membrane parameters of 
bipolar and multipolar interneurons grown for 7 and 15 DIV were analyzed. There 
were significant differences in RMP (-59 ± 2mV at 7 DIV and -69 ± 2mV at 15 DIV), 
input resistance (408 ± 106MΩ at 7 DIV and 37 ± 3 MΩ at 15 DIV) and capacitance 
(25 ± 2pF at 7 DIV and 37 ± 3pF at 15 DIV) in multipolar interneurons at 7 DIV (n=7) 
when compared with neurons grown for 15 DIV (n=11) (E, F, G). Peak inward current 
was measured for multipolar interneurons grown for 7 DIV (-2.1 ± 0.4nA)  and 15 DIV 
(-2.9 ± 0.8nA) (H). RMP (-43 ± 4mV at 7 DIV and -54 ± 2mV at 15 DIV) (I), input 
resistance (1080 ± 123MΩ at 7 DIV and 939 ± 65MΩ at 15 DIV)  (J), capacitance 
(13.5 ± 1pF at 7 DIV and 15 ± 2pF at 15 DIV) (K) and peak inward current (-0.58 ± 
0.1nA at 7 DIV, -0.78 ± 0.2nA at 15 DIV)  (L) was determined for bipolar interneurons 
(7 DIV (n=5), 15 DIV (n=20)). Firing pattern in response to depolarizing current 
injections of multipolar interneurons at 7 DIV and 15 DIV.  Data are presented as 
mean ± SEM. Unpaired t-test *p<0.05, **p<0.01. Scale bar= 14 µm.  
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Figure 2.3. Action potential characteristics of GAD67-GFP positive 
interneurons in vitro.   
 
Action potential (AP) amplitude and AP duration (AP half width) can be calculated 
from current clamp recordings. Action potential amplitude (B) and duration (C) were 
determined for bipolar and multipolar interneurons at 15 DIV. Data is presented as 
mean ± SEM.  Unpaired t-test. 
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Figure 2.4. Electrophysiological characterization of Thy1-YFP positive 
cortical neurons in vitro. 
Phase image of whole-cell patch clamped neurons at 7 DIV (A) and 15 DIV (E), 
patched neurons were YFP positive 7 DIV (B) and 15 DIV (F). Intracellular labeling of 
7 DIV (C) and 15 DIV (G) neurons by Alexa Fluor-568 dye.  Current responses to 
depolarizing voltage steps in 10mV increments from −70mV at 7 DIV (D) and 15 DIV 
(H). Bottom panels show bar graphs of the average electrophysiological data for YFP 
positive neurons at 7 DIV and 15 DIV. RMP of -65 ± 5mV (n=8 cells) at 7 DIV and -70 
± 10mV (n=5 cells) at 15DIV (I). Input resistance of 320 ± 90MΩ (n=8 cells) cells at 7 
DIV and of 170 ± 9MΩ at 15 DIV (n=5 cells) (J). Capacitance of 30 ± 1pF at 7 DIV 
and of 44 ± 6pF (K). Peak inward current of -1.7 ± 0.3nA at 7 DIV  and of -2.9 ± 
0.5nA at 15 DIV on depolarization from −70mV to +50mV. Current clamp in response 
to depolarizing current injections in cortical neuronal cultures at 7 DIV (M) and 15 
DIV (N). Unpaired t-Test *p<0.05. Data are presented as mean ± SEM. Scale bar = 
14 µm. 
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Figure 2.5. Electrophysiological characterization of GAD67-GFP positive 
interneurons at 15 DIV and comparison with passive membrane parameters of 
Thy-1 YFP positive cortical pyramidal neurons.   
Phase image of whole-cell patch clamped bipolar (A) and multipolar interneurons at 
15 DIV (D).  Patched neurons were GAD67-GFP positive bipolar  (B) and multipolar 
(E) cells. Bipolar (C) and multipolar (F) neurons are filled by Alexa Fluor-568 dye 
upon patching.  Passive membrane parameters of bipolar (BP, n=20), multipolar 
interneurons (MP, n=11) and pyramidal neurons (n=8) were analyzed. RMP (G), 
input resistance (H), capacitance (I) and peak inward current at 0mV (J) differed 
between the population of bipolar and multipolar interneurons and the population of 
bipolar interneurons and pyramidal neurons. Current responses to depolarizing 
voltage steps in 10mV increments from −70mV holding potential of GAD67-GFP 
positive neurons grown form 15 DIV.  Three firing patterns were recorded from 
multipolar interneurons indicating that different subpopulations of interneurons might 
be present in this group (K, L, M, n=3, n=5, n=3, respectively). Firing pattern in 
response to depolarizing current injections of bipolar interneurons (BP, n=4) (N). 
Data are presented as mean ± SEM. One-way ANOVA, followed by Bonferroni test  
***p<0.001, ****p<0.0001. Scale bar= 14 µm.  
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2.3.5. Cortical interneurons survive following in vitro axonal injury  
 
As mentioned above bipolar interneurons became depolarized after injury, 
pointing to the possibility that they become unhealthy after injury. To investigate 
neuronal viability after injury, immunocytochemistry was performed at 15 DIV and at 
0, 4 and 24 hours following transection injury in primary cortical cultures derived from 
heterozygous GAD67–GFP knock-in mice. Immunolabeling with antibodies to both 
the calcium binding protein Calretinin and GFP were used to confirm the proportion 
of Calretinin interneurons relative to the total number of GAD67-GFP+ interneurons at 
a close distance from the injury site (at no more than 500µm from the injury site) at 0, 
4 and 24 hours post-injury. The proportion of Calretinin interneurons relative to the 
total number of GFP+ interneurons was analyzed. The number of cells in cortical 
neuronal cultures expressing CR increased between 9 to 12 days in vitro, from 
approximately 15 to 30 percent. The number of Calretinin interneurons reached a 
plateau at 15 DIV, at approximately 27 percent of GFP+ interneurons. After injury 
there was no significant change in the number of CR+ GFP+ interneurons over time 
compared to uninjured cultures (Fig 2.8 A, B).  
 
To further investigate the viability of Calretinin neurons “close” to the injury 
site, immunolabeling to detect activated Caspase 3 was performed. Caspase 3 is a 
protease implicated in the initiation of the neuronal cell death cascade and is 
therefore an important marker of cells entering the apoptotic-signaling pathway (King 
et al., 2013). GFP+ interneurons did not express Caspase 3, indicating that they were 
not undergoing programmed cell death cascade (Fig 2.8 C, D). These results 
indicate that there was no significant apoptosis of interneurons in response to 
transection injury although they had become depolarized after injury.  
 
2.3.6. YFP pyramidal neurons become hyperexcitable after injury in vitro 
 
To determine changes in pyramidal neurons after injury, neurons from Thy1-
YFP transgenic mice were grown for 15 DIV before they were subjected to axonal 
transection. After injury YFP+ neurons were patched at increasing distances from the 
injury site at 4 hours post-injury and compared with YFP+ neurons from uninjured 
cultures. Passive membrane parameters were recorded in voltage clamp and active 
membrane parameters in current clamp in whole cell configuration. YFP+ neurons 
from uninjured cultures had a mean RMP of ~-72mV (n=10 cells), an input resistance 
of ~123MΩ, a capacitance of ~41pF, a peak inward current of ~2.8nA (Fig 2.9 C-E). 
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At 4 hours post-injury there were no significant changes in most passive membrane 
parameters. However the input resistance was altered in neurons close to the injury 
site (less that 500 µm) (Fig 2.9 D, p=0.009). This increase in input resistance was 
coupled to a hyperexcitability of neurons in injured cultures as evidenced by a 
significant decrease in voltage threshold (p=0.029) and significant increase in 
rheobase (minimal current required to fire an action potential) (p=0.008) (Fig 2.9 G, 
H). Furthermore, firing frequency at increasing current injections was also 
significantly increased in pyramidal neurons close to the injury site (p=0.035) (Fig 2.9 
J).  
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Figure 2.6.  Post-injury neurite remodeling of Calretinin interneurons at 15 
DIV. 
 
Representative images and Neurolucida tracings of Calretinin interneurons and YFP 
pyramidal neurons at 4 hours post-injury at increasing distances from the injury site 
(A, B, C, D). Bar graphs represent the percentage of CR or YFP labeled neurites that 
were directed away or towards the injury. There was no significant angle shift found 
between these two populations when neurons were located further than 500µm from 
the injury site at 4 hours post-injury (E, F). CR interneurons located closer to the 
injury site  (less that 500µm) remodeled away from the injury site at 4 hours post-
injury (p=0.014) (G) but not at 0 or 24 hours post-injury (p=0.809, p=0.506 
respectively) (H, I). Two-way ANOVA followed by Bonferroni test. Data is presented 
as mean ± SEM. Scale bar= 50µm. 
 
 
 
 
A    CR B
4 hs PI 0-500µm from the injury site
Away Towards
0
20
40
60
80
Pe
rc
en
ta
ge
 o
f T
ot
al
 N
eu
rit
es
4 hs PI 500-1000µm from the injury site
Away Towards
0
20
40
60
80
Pe
rc
en
ta
ge
 o
f T
ot
al
 N
eu
rit
es
4 hs PI <1000µm from the injury site
Away Towards
0
20
40
60
80
Pe
rc
en
ta
ge
 o
f T
ot
al
 N
eu
rit
es
*
C   YFP D E
F
G
24 hs PI 0-500µm from the injury site
Away Towards
0
20
40
60
80
Pe
nc
en
ta
ge
 o
f T
ot
al
 N
eu
rit
es CR (+)
YFP (+)
0 hs PI 0-500µm from the injury site
Away Towards
0
20
40
60
80
Pe
nc
en
ta
ge
 of
 To
ta
l N
eu
rit
es CR (+)
YFP (+)
H I
500μm
500-1000μm
	   48	  
 
 
Figure 2.7. Post-injury neurite remodeling is subpopulation specific. 
 
Representative image of CR+ GFP+ interneurons at 4 hours post-injury, at less than 
500µm from the injury site (A). Bar graphs represent the percentage of GFP+ or CR+ 
GFP+ labeled neurites that were away or towards the injury. CR+ GFP+ interneurons 
located close to the injury site  (less that 500µm) remodeled away from the injury site 
at 4 hours post-injury (B, p=0.005). GAD67-GFP positive interneurons did not 
remodel away from the injury site at 4 hours post-injury. Two-way ANOVA followed 
by Bonferroni test. Data is presented as mean ± SEM Scale bar= 40µm. 
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Figure 2.8. Proportion of GFP+ interneurons that express Calretinin  at 0, 4 
and 24 hours post-injury.  
 
There were no significant differences found in the proportion of CR+ GFP+ 
interneurons detected within the GFP+ population of interneurons in uninjured or 
injured cultures (A) Representative image of CR+ GFP+ interneurons at 4 hours post-
injury (B) scale bar= 50µm. Representative images of immunolabeling with anti-
activated Caspase 3 antibody and anti-GFP in injured cultures at 4 hours post-injury 
(C, D). Data are presented as mean ± SEM Scale bar= 30µm. 
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Figure 2.9. Post-injury 15 DIV Thy1-YFP positive pyramidal neurons become 
hyperexcitable.  
 
Phase image of a pyramidal neuron 4 hours post-injury located less than 500µm from 
the injury site (A), patched neuron filled with Alexa Fluor-568 dye (B). Bar graphs 
represent the average electrophysiological data for YFP positive neurons in non-
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injured (n=10) and injured (n=12) cultures at 4 hours post-injury. RMP of patched 
YFP positive neurons in non-injured cultures was -72 ± 4mV and in injured cultures 
was -68 ± 2mV (C). Input resistance differed between neurons in non-injured cultures 
(125 ± 20MΩ) and in injured cultures (230 ± 31MΩ) (p<0.01) (D). Capacitance of 
neurons in non-injured cultures (42 ± 4pF)  and injured cultures (51 ± 5pF)  was not 
different (E). No differences were found in peak inward current on depolarization 
from −70 mV to +50 mV in neurons in non-injured cultures (-2.78  ± 0.39nA)  and in 
injured cultures (-2.67 ± 0.31nA) (F). Voltage threshold differed between neurons in 
non-injured cultures (-32.6 ± 2.5mV) and neurons in injured cultures (-40.6 ± 1.8mV)   
(G). Rheobase also differed between neurons in non-injured cultures (187.5 ± 7.2pA)  
and neurons in injured cultures (141.6 ± 8.3) (H). Voltage responses to depolarizing 
current injections of Thy-1 YFP positive neurons at 4 hours post-injury at less than 
500µm from the injury site of non-injured and injured cultures (I) Frequency-current 
plots of neurons in non-injured cultures and in injured cultures (J). Data are 
presented as mean ± SEM. Unpaired t-test *P <0.05; **P <0.01. Frequency-current 
plots were analyzed using a Paired-t-test *P <0.05. Scale bar 80µm (A), 14µm (B).  
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2.4. DISCUSSION 
 
In this Chapter an in vitro model of axonal injury was utilized to investigate the 
response to injury of specific subpopulations of neurons. The use of neurons derived 
from two transgenic mouse strains, the Thy1-YFP mouse and GAD67-GFP mouse 
that express fluorescent proteins in cortical pyramidal and inhibitory neurons, 
respectively, enabled the easy identification and study of specific neuronal 
populations after transection injury. First, the ability of different populations of 
neurons to develop and become functionally mature in vitro was explored. Earlier 
studies have indicated that the neuronal response to injury of mature and immature 
neurons is intrinsically different (Chuckowree and Vickers, 2003, Blizzard et al., 
2007). Therefore, in the current study, an investigation of in vitro functional 
development of primary cortical cultures was carried out. Results indicated that as 
interneurons and pyramidal neurons matured in vitro there was a coordinated change 
in their electrophysiological properties characterized by an increase in the magnitude 
of voltage-gated Na+ currents, a decrease in input resistance, an increase in 
capacitance and eventually, a depolarization of the resting potential that resulted in 
the appearance of a repetitive firing ability (Fig 2.2, 2.4).  
 
The ability of neurons to fire a train of action potentials in response to 
depolarizing current injections correlates with neuronal maturity in motor neurons and 
cortical neurons in slice preparations (Gao and Ziskind-Conhaim, 1998, Picken 
Bahrey and Moody, 2003). It has also been previously reported that action potential 
amplitude and duration are parameters directly related to the maturity of neurons in 
culture (Johnson et al., 2007). These parameters were explored and used to 
compare the functional maturity of bipolar and multipolar subpopulations of 
interneurons. Results indicated that both populations of interneurons investigated 
had reached functional maturity by 15 DIV (Fig 2.3). Furthermore, cortical neurons in 
these cultures had developed firing patterns similar to those described for the 
interneuron population in cortical slices (Markram et al., 2004). Therefore, after the 
analysis of passive and active membrane parameters of interneurons grown for 2 
weeks in vitro, it was concluded that both subpopulations of interneurons have 
reached maturity by 15 DIV and that neurons grown for longer periods in vitro better 
represent mature neurons in vivo (Fig 2.5).  
 
The interneuron population is remarkably diverse. To further characterize the 
culture model used in this Chapter, interneurons were subdivided into two major 
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categories: bipolar and multipolar, and significant differences in the passive 
membrane parameters of these populations indicated that they represent 
independent populations of cells. Furthermore, the action potential firing 
characteristics of GAD67-GFP interneurons revealed at least four different firing 
patterns. Accumulating evidence suggests that separate classes of neocortical 
interneurons have specific electrophysiological characteristics (Gupta et al., 2000, 
Kawaguchi, 2001, Markram et al., 2004, Dumitriu et al., 2007). Results in this 
Chapter indicate that at least four different populations of GAD67-GFP positive 
interneurons are present in culture, confirming that interneurons grown in vitro 
maintain some of the important subclass diversity found in the cortex (Fig 2.5).  
 
Further studies in this Chapter were aimed at investigating post-injury 
changes in the inhibitory and excitatory neurons in culture. There is evidence 
indicating that interneurons are more plastic than pyramidal neurons. It has been 
reported before that interneurons exhibit dynamic arbor rearrangements in the adult 
visual cortex while pyramidal neurons remain stable (Lee et al., 2006, Lee et al., 
2008). Moreover, previous experiments in the Dickson lab group have found 
differences in post-injury structural plasticity between Calretinin interneurons and 
pyramidal neurons (Blizzard et al., 2011). In the current study analysis of post-injury 
neurite angle indicated that CR interneurons remodel their processes away from the 
injury site while there were no changes found in pyramidal neurons. These results 
further support intrinsic differences in the neuronal response to injury between 
different neuronal subtypes (Fig 2.6). A possible limitation of this part of the study is 
the fact that analysis of dendritic angle after injury was performed in fixed samples. 
Ideally dendritic orientation would be investigated using live-imaging of fluorescently 
labeled CR positive interneurons after injury.  
 
While there is extensive evidence indicating that inhibitory interneurons have 
a greater propensity to remodel, it is still unclear if all interneuron subtypes are 
uniform in their capacity for structural change. Previous studies indicate that in the 
naïve brain dendritic branch tip remodeling of interneurons in the adult visual cortex 
is mainly contained within a superficial strip of layer II/III of the cortex (Lee et al., 
2006). Moreover it has been reported that dendritic remodeling of GABAergic 
interneurons is not determined by genetic lineage but rather is a general feature of all 
interneuron subtypes imposed only by cortical laminar circuitry (Lee et al., 2006, Lee 
et al., 2008, Chen et al., 2011). Although these previous elegant studies have 
indicated that there are no subtype specific differences in the capacity of structural 
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remodeling in interneurons, results in this Chapter point more to a cell type specific 
effect given that neurite remodeling after injury was found be restricted to CR 
interneurons in vitro. The current results seem to be contradicting previous studies, 
however, closer analysis reveals that this may not be the case. As mentioned above, 
it has been demonstrated that plastic interneurons are found in layer II/III of the 
cortex.  Interneurons that populate layers II/III are mainly large basket cells, nest 
basket cells, Martinotti cells and bipolar cells. Lee at al. in 2006 reported that plastic 
interneurons in layer II/III in the cortex were not Pavalbumin, Somatostatin or 
Cholecystokinin positive. Given those results it is unlikely that Martinotti cells (usually 
Somatostatin positive) or Pavalbumin or Cholecystokinin positive large and nest 
basket cells were the plastic interneurons described in these studies. This implies 
that Calbindin or Calretinin positive basket cells or bipolar Calretinin cells were the 
interneurons defined to have a greater propensity to structural plasticity. 
Furthermore, it has been reported that post-injury plasticity could be specific to the 
Calretinin subpopulation of interneurons (Blizzard et al., 2011). In conclusion in this 
Chapter using an in vitro model of neuronal injury it was demonstrated that 
remodeling of dendritic arbors after injury is specific to the subpopulation of Calretinin 
interneurons and is not a general feature of all interneurons. This indicates that 
Calretinin positive interneurons may be more intrinsically plastic than other 
population of interneurons (Fig 2.7).  
 
After injury there is an important release of neurotransmitters, neurotrophic 
factors and calcium (Weber et al., 2001, Morrison et al., 2011). Given that 
remodeling was found to be restricted to an area close to the injury site and at an 
early post-injury time point, it is plausible that the release of these diffusible factors 
around an injury site might have differential effects on specific cell types mediating 
neurite remodeling on Calretinin interneurons. Although this would need to be further 
investigated.  
 
To gain insights into the functional consequences of dendritic remodeling, 
post-injury patching of Calretinin interneurons was attempted. Bipolar interneurons 
were targeted since they typically express Calretinin (Markram et al., 2004). Post-
injury patching of bipolar interneurons proved to be technically very challenging and 
was not successful. As a balance of excitation and inhibition is critical for normal 
cortical function it was hypothesized that the alterations in the dendritic arbor of 
cortical interneurons might produce an imbalance in cortical excitation. In order to 
test this hypothesis post-injury patch-clamp of Thy-1 YFP positive pyramidal neurons 
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was performed. Results indicated that pyramidal neurons had become 
hyperexcitable presenting an increased firing frequency four hours after injury (Fig 
2.9). Further analysis of electrophysiological parameters demonstrated that these 
cells had an increased input resistance. An increase in input resistance has been 
previously reported in in vitro models of partially isolated cortex, the undercut injury 
model and also in in vivo models of the chronically injured epileptogenic cortex and 
has been linked to an increased firing frequency (Prince and Tseng, 1993, Jin et al., 
2005, Jin et al., 2006). Furthermore, an increase in input resistant would indicate that 
less current would be necessary to excite these cells and this was demonstrated by a 
decrease in rheobase.  Moreover, YFP+ neurons in injured cultures close to the injury 
site presented a significant increase in voltage threshold and a steeper relationship 
between action potential frequency and depolarizing current. There were no 
differences found in RMP, peak inward current or capacitance suggesting that the 
overall size and complexity of the neurons in injured and uninjured cultures was 
similar and therefore suggesting that neurons that were patched had not been 
directly injured (Fig 2.9).  
 
Neuronal excitability can be influenced by afferent synaptic excitatory and 
inhibitory balance as well as an intrinsic excitability of the neuron, which in turn is 
mainly determined by its membrane proteins and their activity (Smith et al., 2015). 
The differences found in the electrophysiological parameters in pyramidal neurons 
after injury in the current study would point to an increase in intrinsic excitability of 
these neurons. Several mechanisms can be proposed as responsible for this effect. 
Firstly, the increased intrinsic excitability found could be related to the initiation of the 
sprouting response present at 4 hours post-injury given that maladaptive axonal 
sprouting of excitatory neurons has been previously linked to hyperexcitability (Prince 
et al., 1997, Prince et al., 2009). Secondly, it is plausible that the presence of 
diffusible factors released  after injury like excitatory neurotransmitters that might act 
via metabotropic receptors are responsible for the increased excitability of pyramidal 
neurons. Thirdly, it is also likely that a decrease in inhibitory input onto pyramidal 
neurons, due to interneuron remodeling, could drive the increased excitability found. 
Calretinin interneurons have been described to be mainly interneuron selective 
inhibitory cells that specifically target dendritic inhibitory interneurons (Gulyas et al., 
1996, Caputi et al., 2009). The fact that they target almost exclusively other subtypes 
of interneurons indicates that even though Calretinin interneurons represent only 20 
percent of the total interneurons in a culture, changes in this subpopulation could 
have larger downstream effects than the expected due to their number. It is therefore 
	   56	  
hypothesized that neurite remodeling in Calretinin interneurons could have an 
important impact in the whole inhibitory circuit. Since they target almost exclusively 
other subtypes of interneurons it is hypothesized that their neurite remodeling could 
have larger downstream effects than at first expected due to their proportion in the 
total population of interneurons. In support of this hypothesis remodeling of Calretinin 
interneurons and hyperexcitability of pyramidal neurons were found in the same 
region of the injured coverslip and at the same post-injury time point. Thus is likely 
that Calretinin interneuron neurite remodeling, post-injury axonal sprouting and the 
presence of diffusible factors release form the injury site are all contributing factors in 
the imbalance of excitation and inhibition linked to the development of post-traumatic 
hyperexcitability in this model. 
 
Primary cortical neuronal cultures can replicate many specific features of the 
CNS and allow the study of key neuronal changes in a simple cellular environment 
that is more amenable to experimental manipulation. In the current study the use of 
primary neuronal cultures from cells derived from knock-in transgenic mice allowed 
the analysis of excitatory and inhibitory neurons after injury. Results in this Chapter 
build on previous evidence indicating that there is a differential response to injury of 
excitatory and inhibitory neurons specifically Calretinin interneurons. Furthermore, 
the results indicate that there is a possible link between post-injury plasticity of 
inhibitory neurons and altered excitability. Additional studies presented in Chapter 3 
investigating inhibitory synaptic input onto pyramidal neurons, further contribute to a 
better understanding of the mechanisms involved in increased excitability after injury.  
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3. MILD TRAUMATIC INJURY INDUCES MORPHOLOGICAL CHANGES IN 
CALRETININ INTERNEURONS AND REDUCES GABAERGIC INHIBITION IN THE 
CORTEX  	  
3.1 INTRODUCTION 
 
Mild injuries account for approximately 80 percent of the total number of brain 
injuries that occur globally (Roozenbeek et al., 2013). After a mild injury to the brain 
most patients do not usually display any clear morphological or functional 
abnormalities (Bigler and Maxwell, 2012). While most patients recover completely 
from a mild brain injury, up to a quarter can have persistent cognitive, behavioral and 
emotional complaints and a small proportion can develop post-traumatic epilepsy 
(McAllister et al., 2006, Kennedy et al., 2007, Xydakis et al., 2008, Vasterling et al., 
2009, Combs et al., 2015). The development of these clinical complications may be 
attributed to the activation of plastic adaptive and maladaptive processes after injury. 
While adaptive changes potentially lead to recovery, maladaptive ones can result in 
injury-induced reorganization of neuronal networks that may worsen outcomes after 
injury. The specific mechanisms involved in the functional alterations after injury 
remain poorly understood and elucidating these mechanisms continues to be a 
fundamental priority in neuroscience research.  
 
Traumatic injuries are often followed by alterations in the excitability of surviving 
cortical networks. The role of glutamate signaling in the pathology of TBI in particular 
has been well described. There is vast evidence indicating that acute post-traumatic 
glutamate release is related to excitotoxicity that leads to neuronal injury, death and 
dysfunction; and that delayed disruption of glutamate circuits leads to further 
cognitive and motor deficits after TBI (Guerriero et al., 2015).  It is assumed that the 
perturbations in the glutamate circuit finally result in an imbalance of excitatory and 
inhibitory synaptic transmission. There is considerable evidence from animal studies 
that mild TBI induce pathology in the hippocampus and the thalamus, where 
disruption of the necessary balance between excitation and inhibition can be linked 
to post-traumatic epilepsy and cognitive impairment (Hunt et al., 2011, Pavlov et al., 
2011, Huusko and Pitkanen, 2014, Almeida-Suhett et al., 2015, Drexel et al., 2015, 
Girgis et al., 2016).  Modifications in the inhibitory network have been well described 
in the hippocampus with reports indicating that mild TBI causes alterations in the 
number of GABAergic interneurons and changes in the expression of various GABA 
receptor subunits, leading to a reduction in inhibitory and increase in excitatory post-
synaptic currents (Hunt et al., 2011, Almeida-Suhett et al., 2015, Drexel et al., 2015). 
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Altered neurotransmission has also been found in other regions of the brain after 
mild TBI, for example the basolateral amygdala where it has been linked to post-
traumatic anxiety (Almeida-Suhett et al., 2014).  
 
Recent evidence indicates that the normal balance between excitatory and 
inhibitory neurotransmission is also disrupted in the cerebral cortex after mild TBI 
(Ding et al., 2011, Smith et al., 2015, Ping and Jin, 2016). Intrinsic 
electrophysiological changes were detected in layer 5 pyramidal neurons, as well as 
increased excitability (Greer et al., 2012, Hanell et al., 2015b). As mentioned before 
while there is accumulating evidence of an increased excitatory drive in the cortex 
after mild injury,  there is still a lack of information regarding pathogenic changes in 
inhibitory circuits following injury to the brain. Thus the aim of this Chapter was to 
further investigate plastic alterations in the cortical inhibitory network after mild injury 
to the brain using a clinically relevant in vivo model of focal and diffuse injury. 
Morphological studies into specific subpopulations of interneurons were performed in 
order to build on the in vitro observations presented in Chapter 2.  
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3.2. MATERIALS AND METHODS 
 
3.2.1. Fluid percussion injury model 
 
All experiments were approved by the Animal Ethics Committee of the 
University of Tasmania and performed in accordance with the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purposes (A0014233). 
Animals were housed in individually ventilated cages at 20°C, on a 12 hour light-dark 
cycle, with access to food and water ad libitum. Male transgenic Thy1-YFP-H or 
GAD67-GFP mice were utilized in this study. For immunohistochemical labeling and 
analysis only GAD67-GFP mice were used.  
 
Adult animals were exposed to mild TBI at 8-10 weeks of age in the form of a 
lateral fluid percussion injury (FPI). Animals were anesthetized with isoflurane and 
placed in a stereotaxic frame, the scalp was opened, and the fascia scraped from the 
skull. Using a trephine, a 3 mm diameter craniectomy was performed over the 
somatosensory cortex and a needle hub (3 mm inner diameter) was secured above 
the skull opening.  Post craniectomy (1-2 hours later) animals were anesthetized with 
isoflurane anesthesia. Once surgical anesthesia was achieved the isoflorane was 
withdrawn, the hub was filled with saline and mice were connected to the fluid 
percussion injury device. Once a normal breathing pattern resumed, but before 
sensation was restored, an injury was induced by releasing the pendulum onto a 
fluid-filled piston which induced a brief fluid pressure pulse upon the intact dura (1.4 
± 0.10 atmospheres). Animals were allowed to partially recovery from anaesthesia 
before injury since the righting time (the time taken for the mouse to regain its 
righting reflex) was used as a measure of brain injury. After injury the hub was 
removed and the animal was placed under isoflurane for suturing. Sham animals 
received the same surgeries, without receiving the injury.  
 
To identify cells generated in the post-injury period, the thymidine analogue 5-
ethynyl-2′-deoxyuridine (EdU, 0.2mg/ml; Invitrogen), was administered ad libitum via 
the drinking water, as previously described (Clarke et al., 2012). Delivering EdU in 
the drinking water is a standard method for tracing newly generated cells over longer 
periods of time (Clarke et al., 2012, Wang et al., 2016).  EdU is incorporated into the 
DNA of dividing cells during S phase of the cell cycle. Mice were sacrificed at 1 day, 
1 week and 4 weeks post-injury. Mice (n=6 FPI injured and n=6 sham injured per 
time point) were terminally anaesthetized (sodium pentobarbitone, 140mg/kg, i.p.) 
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and transcardially perfused with 4% paraformaldehyde in PBS.  Brains were post-
fixed in 4% PFA-PBS overnight and stored at 4°C in PBS containing 0.1% w/v 
sodium azide (Sigma Aldrich, Australia).  
 
For sectioning brains were embedded in 5% (w/v) molecular grade agarose 
(Bioline Australia Pty Ltd, NSW Australia) dissolved in PBS. Coronal sections (50µm 
thick) were produced using a Leica VT1000S vibratome (Biosystems, Australia), and 
collected as floating sections into 24 well plates (Corning Life Sciences, USA) 
containing PBS sodium azide.  
 
3.2.2. Immunohistochemistry and EdU detection 
 
 Free-floating sections were stored in darkness at 4°C until processed for 
immunohistochemistry. The coronal brain sections were processed using standard 
immunohistochemical methods.  Somatosensory cortices containing the injury site 
were identified by referring to anatomical landmarks such as the appearance of the 
lateral ventricles, the third ventricle and the corpus callosum.  Sections were 
incubated for 24 hours at room temperature with primary antibodies that included, rat 
anti-GFP protein to detect YFP or GFP (1:3,000; Nacalai tesque) and rabbit anti-CR 
(1:1000; Swant) in PBS containing 0.3% Triton X-100. Sections were then washed 
three times in PBS and incubated with isotype- and species-specific Alexa Fluor-488 
or -568; conjugated donkey anti-rabbit (1:1000) or goat anti-rat (1:1000) (Thermo-
Fisher Scientific, Australia) for two hours at room temperature. After the final 
immunohistochemistry washes EdU was visualized using the AlexaFluor-647 Click-iT 
EdU kit (Life Technologies, Australia), as previously described (Young et al., 2013). 
Sections lacking primary antibodies were prepared to control for any non-specific 
binding of secondary antibodies.  
 
Quantification of the total number of interneurons was based on the 
endogenous expression of GFP enhanced by the use of an anti-GFP antibody on 
GAD67-GFP transgenic mice. Quantification of the subpopulation of Calretinin 
interneurons was based on their expression of this calcium binding protein. 
Interneuron numbers were quantified in the injury site in the supragranular (layers I-
IV) and infragranular (layers V-VI) lamina in 6 age-matched sham and 6 FPI mice per 
time point. Images were collected using an UltraVIEW spinning disk confocal 
microscope running Volocity Software (PerkinElmer, Australia) equipped with a Plan 
Apo 60x/1.20 water objective (Nikon, USA) configured to capture 30µm Z-stacks 
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(slices 1µm apart). The supragranular and infragranular lamina were defined as two 
adjacent fields containing cortical layers I-IV and V-VI, respectively, and demarcated 
as extending from the pial surface to the grey-white matter border. To perform 
unbiased and inclusive quantitative analysis, ImageJ freeware was utilized for 
automation of cell counts.  
Neuronal morphology was characterized using NeurolucidaTM  software. 
Calretinin positive cells were assessed for alterations to Calretinin-labeled neurites 
(including axons and dendrites). Tracing was performed in 30µm Z-stacks (slices 
1µm apart) to allow for  accurate reconstruction of neurons and avoid background 
fluorescence or overlapping of Calretinin positive processes.  
 
3.2.3. Electrophysiological characterization of neurons in vivo  
 
Thy1-YFPH or GAD67-GFP mice were exposed to either FPI or sham injuries 
at 8 weeks of age. Following cervical dislocation, mice were decapitated and their 
brains dissected into ice-cold sucrose solution containing: 75mM sucrose, 87mM 
NaCl, 2.5mM KCl, 1.25mM NaH2PO4, 25mM NaHCO3, 7mM MgCl2, and 0.95mM 
CaCl2.  Acute coronal slices (300 µm) were prepared using a Leica VT1200s 
vibratome, and incubated at 31.7°C for ≥ 45 minutes in artificial cerebral spinal fluid 
(ACSF) containing: 119mM NaCl, 1.6mM KCl, 1mM NaH2PO4, 26.2mM NaHCO3, 
1.4mM MgCl2, 2.4mM CaCl2, and 11mM glucose (300 ± 5 mosm/kg).  During 
recordings, slices were perfused with ACSF containing 500nM tetrototoxin and 1mM 
kynurenic acid, saturated with 95% O2 / 5% CO2 (all sigma). Whole cell recordings 
were obtained from layer V pyramidal cells just below the point of injury, identified by 
the shape of the cell soma and presence of a long apical dendrite.  Neurobiotin (1.5 
mg/ml) was included in the intracellular solution and slices were recovered for 
histological processing. Recording electrodes were prepared from glass capillaries 
and had a resistance of 3-5 MΩ when filled with an internal solution containing 
120mM cs-methanesulfonate, 20mM HEPES, 0.4mM EGTA, 5mM TEA, 2mM MgCl2, 
2.5mM MgATP, 0.3mM GTP and set to a pH of 7.2-7.3 and an osmolarity of 280 ± 5 
mOsm/kg. Recordings were collected using a HEKA patch clamp EPC800 amplifier, 
with a holding potential of 0 mV. Recordings were made using a gap free protocol for 
3 minutes and 10 seconds, sampled at 50kHz and filtered at 1kHz using PClamp10 
software (Molecular Devices). Data was not included in the analysis if the access 
resistance was ≥ 20 MΩ, or if the access resistance changed by ≥ 10% during the 
course of the recording.  Data collection was carried out only if the recordings were 
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stable for more than 3 minutes.  Mini inhibitory post-synaptic currents (mIPSCs) were 
defined as having an amplitude ≥ 8 pA, and were analysed using the MiniAnalysis60 
program (Synaptosoft, USA). Post-recording, the patch electrode was removed from 
the neuron, which was later identified by the detection of neurobiotin with an Alexa 
Fluor 594 conjugated anti-streptavidin antibody (Molecular Probes™; 0.1% triton-X-
diluent detergent), to confirm that recorded cells were indeed layer V pyramidal 
neurons in the injury site. 
 
3.2.4. Statistical analysis 
All data was analyzed using a two-way analysis of variance followed by 
Bonferroni post hoc tests (GraphPad Prism, version 6.0) for group and regional 
comparisons. Average values were expressed as means ± standard error of the 
mean. For electrophysiological comparisons, two-tailed t-tests were performed. A p-
value <0.05 was considered significant. 
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3.3. RESULTS 
 
3.3.1. Mild TBI does not induce cortical loss or contusion  
 
Mild brain injury was induced in GAD67-GFP mice using the lateral fluid 
percussion injury model. Mild injury to the brain was confirmed by a short post-injury 
righting time (between 2-4 minutes) and no mortality after injury (Table 1) (Alder et 
al., 2011). Mild FPI induced a transient suppression of the righting reflex in all injured 
animals of 2.60 ± 0.58 min that was significantly longer than that of 0.15 ± 0.10 min 
for sham injured animals (p<0.001). Furthermore, no significant difference in righting 
reflex suppression was noted between injury groups of 1 day, 7 days and 28 days 
post-injury. Indicating that all groups received injuries of comparable severity. 
Moreover, there were no significant differences in age and weight between the sham 
operated and FPI injured mice or between time groups. A transient apnea was 
observed in several animals following injury (Table 1). This apneic episode was 
usually of short duration (3-5 seconds) and resolved spontaneously without 
intervention. 
 
After lateral fluid percussion injury, qualitative histological observation of the 
brain revealed that mild injury to GAD67-GFP mice does not result in contusion, 
intraparenchymal hemorrhage or cortical loss (Fig 3.1).  
 
3.3.2. Mild TBI does not lead to interneuron loss 
 
In order to determine whether mild TBI had an effect on the population of 
interneurons, the total number of GFP positive interneurons was examined in 
GAD67-GFP mice at 1 day, 7 days and 28 days post-injury. Coronal cortical sections 
from sham and FPI injured mice ipsilateral and contralateral to the injury site were 
immunostained to detect GFP (Fig 3.2 A, B; 7 days PI). The total number of GFP 
positive interneurons was quantified, revealing that mild brain injury does not affect 
the total number of interneurons present in the ipsilateral or contralateral 
somatosensory cortex at 1, 7 or 28 days post-injury (Fig 3.2 C; p=0.85). As 
subpopulations of interneurons populate specific cortical layers, the total number of 
interneurons in different layers of the cortex was also analyzed. There was no 
significant influence of injury on the number of interneurons present in the 
supragranular (Fig 3.2 D; layers I-IV; p=0.77) or infragranular layers (Fig 3.2 E; layers 
V, VI; p=0.66). These results indicate that there were no regional specific changes in  
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Table 3.1. Summary of age, weight, fluid pulse pressure delivered and the 
righting time of sham or FPI GAD67-GFP mice. 
 
 Injured animals had an increased righting time when compared to sham animals. 
There were no differences in age or weight between groups. There were no 
differences in the pulse of pressure received by injured groups. Data are presented 
as mean ± SEM. Two-way ANOVA, followed by Bonferroni test (**p<0.01). 
 
 
1 day PI 7 days PI 28 days PI
Sham FPI Sham FPI Sham FPI
n=6 n=6 n=6 n=6 n=6 n=6
Age (weeks)
Weight (g)
FPI (atm)
Righting time (min)
Apnea (sec)
11.3 ± 0.8 9.6 ± 0.7 11.2 ± 0.5 11.3 ± 0.6 12.7 ± 0.2 12.5 ± 0.5
28.6 ± 0.9 27.3 ± 1.4 29.2 ± 0.6 29.9 ± 0.9 26.0 ± 0.8 26.2 ± 1.1
NA 1.44 ± 0.10 NA 1.37 ± 0.12 NA 1.39 ± 0.15
0.2± 0.1 2.16 ± 0.53** 0.1± 0.1 2.67 ± 0.61** 0.1 ± 0.1 2.04 ± 0.30**
NA NA NA2.6 ± 0.8 4.1 ± 0.5 3.7 ± 0.8
	   65	  
 
 
 
Figure 3.1. Representative image of post-injury cortical tissue from a 
GAD67-GFP mouse containing the injury site.  
 
Qualitative observation of post-injury cortical tissue indicated that there was no clear 
cortical loss after injury at any of the time point post injury analyzed, however 
quantitative analysis was not within the scope of this thesis. Immunolabeling for 
Calretinin (CR), EdU and GFP contralateral and ipsilateral to the injury site after FPI. 
Scale bar=100µm 
 
 
 
 
 
 
 
 
 
Contralateral
Ipsilateral
EdU
CR
GFP
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particular subpopulations of interneurons after mild TBI.  
 
3.3.3. Calretinin interneurons survive for at least 4 weeks following a mild TBI  
 
Previous results in Chapter 2 point to Calretinin interneurons as an important 
population of interneurons with a unique response to injury. To build on the earlier 
results the population of Calretinin interneurons was investigated after mild TBI in 
GAD67-GFP mice at 1, 7 and 28 days post-injury. Coronal cortical sections from 
sham and FPI mice were immunostained with anti-Calretinin antibody to detect 
Calretinin positive interneurons (Fig 3.3 A, B; 7 days PI). The total number of 
Calretinin positive interneurons was quantified ipsilateral and contralateral to the 
injury site. Mild brain injury had no effect on the total number of Calretinin 
interneurons ipsilateral or contralateral to the injury site at any of the post-injury time 
points analyzed when compared to sham mice (Fig 3.3 C; p=0.32).  
 
Calretinin expressing interneurons include bipolar cells (layers II-VI), double 
bouquet cells (layers II-VI) and bitufted cells (preferentially located in layers I-IV) 
(Markram et al., 2004). To further investigate possible injury effects on specific 
subpopulations of Calretinin interneurons the number of Calretinin interneurons in 
different layers of the cortex was analyzed. There were no significant differences 
found in total number of Calretinin interneurons in the supragranular (Fig 3.3 D; 
layers I-IV; p=0.55) or infragranular layers (Fig 3.3 E; layers V, VI; p=0.50) of the 
cortex at any of the post-injury time points examined.  These results further indicate 
that mild TBI does not lead to the loss of specific subpopulations of interneurons.  
 
3.3.4. Mild TBI induces cell proliferation but not neurogenesis 
 
In order to investigate the potential induction of neurogenesis after injury, 
EdU was administered via the drinking water to sham and FPI mice for 1, 7 or 28 
days post-injury. The number of newly generated cells that were EdU labeled was 
quantified in the ipsilateral and contralateral cortex of sham and FPI mice (Fig 3.4 A, 
B). There was no significant increase in the number of EdU labeled cells in the 
somatosensory cortex at 1 day post-injury, ipsilateral or contralateral to the injury site 
when comparing sham or FPI mice.  However the number of EdU positive cells 
detected at 7 days post-injury was significantly increased in the ipsilateral cortex of 
FPI and sham operated mice compared to their contralateral cortices. There was 
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also a significant increase in the number of EdU positive cells in FPI mice relative to 
sham mice ipsilateral to the injury site at 7 days post-injury. EdU immunopositive 
nuclei were rarely observed in tissue sections contralateral to the injury site. The 
increase in EdU positive cells was maintained in the ipsilateral cortex of Sham and 
FPI animals by 28 days post-injury indicating that there was no death of labeled cells 
at this later post-injury time points (Fig 3.4, E, F).  
To determine if mild TBI induced interneuron generation or Calretinin 
interneuron production the presence of GFP+ EdU+ and of CR+ EdU+ interneurons 
was evaluated. There were no newly generated GFP+ interneurons or CR+ 
interneurons detected in the injured cortex ipsilateral or contralateral to the injury site 
in the FPI or sham animals at any of the post-injury time points analyzed (0 GFP+ 
EdU+ cells from a minimum of 200 GFP+ cells per section per animal and 0 CR+ EdU+  
cells from a minimum of 25 CR+ cells per section per animal)  (Fig 3.4 G, H).  
3.3.5. Mild TBI induces morphological changes in Calretinin interneurons  
 
Results in Chapter 2 indicate that Calretinin interneurons respond to 
transection injury by rearranging their dendritic arbors away from the injury site. In 
order to determine if Calretinin interneurons respond to mild diffuse and focal injury 
to the brain in a similar fashion, Calretinin interneurons found in the injury site and 
contralateral to the injury site at 7 and 28 days post-injury were examined and their 
morphology was traced from confocal stacks using Neurolucida software. After 
tracing and reconstruction of interneurons, parameters such as mean dendritic 
length, soma size and branch order and number were calculated using Neurolucida 
Explorer. At 7 days post-injury it was determined that the total length of the dendritic 
arbor of Calretinin interneurons was reduced in the ipsilateral side of FPI mice 
relative to sham control animals (64 neurons were analyzed per mouse for n=6 mice 
per group, two-way ANOVA, p=0.004). However this effect was not maintained in the 
long-term as total dendritic length was equivalent for Calretinin interneurons in the 
ipsilaretal cortex of sham and FPI mice by 28 days post-injury (Fig 3.5 B, C). No 
morphological differences were detected in neurons on the contralateral side of sham 
or PFI injured mice at 7 or 28 days post-injury (Fig 3.5 A, B, C, Two-way ANOVA, 
p=0.22).  
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Figure 3.2. The number and distribution of interneurons is unaltered in the 
brain of GAD67-GFP mice. 
 
Representative image of somatosensory cortex ipsilateral to the injury in sham (A) 
and FPI (B) mice at 7 days post-injury immunolabeled for GFP (A, B). The total 
number of GFP positive interneurons was determined in the cortex, in 3 sections 
ipsilateral and 3 sections contralateral to the injury site, from each of the 6 age-
matched sham and 6 FPI mice that were analyzed per time point (C). Quantification 
of the density of interneurons in the superficial or supragranular layers of the cortex 
(layer I-IV) (D) and in the deep or infraganular layers of the cortex (layer V, VI) (E). 
Data are presented as mean ± SEM. Two-way ANOVA, followed by Bonferroni test. 
Scale bar=80µm.  
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Figure 3.3. Mild brain  injury does not alter Calretinin interneuron number in 
any layer of the somatosensory cortex of GAD67-GFP mice. 
 
Representative image of ipsilateral cortical tissue derived from sham and FPI mice at 
7 days post-injury immunolabeled for Calretinin (A, B). The total number of Calretinin 
interneurons was determined across all layers of the cortex in 3 sections ipsilateral 
and 3 sections contralateral to the injury site from each of the 6 age-matched sham 
and 6 FPI mice that were analyzed per time point (C). The number of Calretinin 
interneurons per area of cortex was also determined in the superficial or 
supragranuar layers of the cortex (layer I-IV) (D) and in the deep or infraganular 
layers of the cortex (layer V, VI) (E). Data are presented as mean ± SEM. Two-way 
ANOVA, followed by Bonferroni test. Scale bar=80µm. 
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A more detailed analysis of the number of dendritic branches and length of 
individual dendritic branches of Calretinin interneurons was carried out in order to 
determine if the differences found in total dendritic length in the injured cortex were 
due to a reduction in individual branch length or a possible decrease in cell 
complexity reflected in reduced branch number. Results indicate that Calretinin 
interneurons in the injured cortex at 7 days post-injury had a reduced dendritic 
complexity given that a reduction of secondary order dendrites in the ipsilateral side 
of the FPI mice was found (Fig 3.5 D, 2-way ANOVA, p<0.02). No differences were 
found in dendritic arbor complexity at 28 days post-injury (Fig 3.5 E, Two-way 
ANOVA, p=0.09). 
 
Comparisons of Calretinin interneurons dendritic branch number at different 
time points post-injury indicate that the changes in dendritic arbor complexity present 
at 7 days post-injury were no longer detected at 28 days post-injury. Calretinin 
interneurons returned to control levels of complexity by 28 days post-injury. There 
was a significant increase in the number of secondary order processes at 28 days 
post-injury compared to 7 days post-injury ipsilateral and contralateral to the injury 
site and an increase in tertiary order processes ipsilateral to the injury site at 28 days 
post-injury respect to 7 days post-injury (Fig 3.5 F, G Two-way ANOVA, p<0.004). 
Moreover there were no differences found in soma size or length of individual 
dendritic branches in the injured cortex compared to sham controls at any of the 
post-injury time points analyzed (Fig 3.5 F, G Two-way ANOVA, p=0.49, p=0.58, 
respectively).  
 
Overall it was determined that Calretinin interneurons in the injured cortex at 
7 days post-injury were significantly less complex (Fig 3.5 J) than Calretinin 
interneurons in the sham control mice (Fig 3.5 K). By 28 days post-injury Calretinin 
interneurons were more complex than at 7 days post-injury and had regained a level 
of complexity similar to Calretinin neurons analyzed in the sham control animals.  
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Figure 3.4. Mild TBI does not stimulate cortical interneuron generation in the 
mature brain. 
 
In order to visualize cells born following injury, GAD67-GFP mice received EdU via 
the drinking water for 1, 7 or 28 days post-injury. Representative image of EdU+ cells 
in cortical tissue derived from sham and FPI mice after 7 days of labeling (A, B). 
Scale bar=80µm. Quantification of the number of EdU+ cells in the somatosensory 
cortex of sham or FPI mice revealed no significant increase in the number of EdU 
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labeled cells at 1day post-injury (C). There was a significant increase in the number 
of EdU labeled cells at 7 days post-injury in the ipsilateral cortex of FPI mice 
compared to the contralateral side and the ipsilateral cortex of sham mice (D). At 28 
days post-injury there was a significant increase in the number of EdU+ cells in the 
ipsilateral cortex of sham and FPI mice compared to the contralateral cortex (E). 
Analysis of EdU+ cells over time showed a significant increase at 7 days post-injury in 
the ipsilateral cortex of FPI mice relative to 1 day post-injury and no overall 
significant changes at 28 days post-injury compared to 7 days post-injury (F). 
Representative images of the ipsilateral cortex of GAD67-GFP mice after mild FPI 
immunolabeled for GFP+ EdU+ and CR+ EdU+ (G, H). Two-way ANOVA, followed by 
Bonferroni test  *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Data are presented as 
mean ± SEM Scale bar=60µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
	   75	  
3.3.6. Reduced synaptic inhibition in layer V pyramidal neurons after mild TBI  
 
To determine whether the alterations in the dendritic arbor of Calretinin 
interneurons after injury reflect a decrease in synaptic transmission in the injury site, 
whole cell patch clamp recordings from Layer V pyramidal neurons from sham and 
FPI Thy1-YFP-H or GAD67-GFP mice were made. FPI animals received a pulse of 
pressure onto the dura of 1.46 ± 0.04 atmospheres. There was a significant 
difference between the righting time of sham (0.13 ± 0.02 minutes) and FPI animals 
(3.06 ± 1.12 minutes; p<0.0001) indicating that FPI mice had received a mild cortical 
injury (Alder et al., 2011). There were no significant differences in age or weight 
between the sham (age 10.4 ± 0.31 weeks; weight 27 ± 0.71 grams, (n=5)) and FPI 
groups (age 10.3 ± 0.13 weeks; weight 28.8 ± 0.34 grams, (n=7)) exposed to mild 
brain injury. During electrophysiological recordings neurons were filled with 
Neurobiotin allowing for post-recording histological characterization of the cell to 
confirm its location in layer V of the somatosensory cortex in the region underlying 
the craniectomy (Fig 3.6 A, B). 
 
Electrophysiological data revealed no significant differences in capacitance 
(sham 58.5pF ± 9.2pF, FPI 48.1pF ± 3.5pF, p=0.268; two-tailed t-test (data not 
shown)) in the injured group compared to the sham group. Miniature inhibitory 
postsynaptic currents (mIPSCs) were recorded from Layer V pyramidal neurons from 
sham and FPI mice at 7 days post-injury (Fig 3.6 C). The average amplitude of the 
mIPSCs was equivalent between sham (12.7pA ± 0.8pA) and injured mice (13.5pA ± 
0.7pA) (p=0.491, two-tailed t-test, Fig 3.6 D). Pyramidal neurons in the 
somatosensory cortex of injured mice received significantly fewer inhibitory synaptic 
inputs compared to sham mice as evidenced by a decrease in frequency of mIPSCs 
from 1.46 ± 0.26 Hz to 0.68 ± 0.12 Hz (p<0.0061, two tailed t-test, Fig 3.6 E). There 
were no differences found in mIPSCs rise (sham 4.33ms ± 0.64ms, FPI 4.78ms ± 
0.71ms, p=0.67, two tailed t-test, Fig 3.6 F) or decay time (sham 7.38ms ± 0.95ms, 
FPI 13.32ms ± 2.74ms, p=0.14, Paired  t-test, Fig 3.6 G). 
 
Overall results showed alterations in mIPSCs frequency but not amplitude 
after mild brain injury.  
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Figure 3.5. Calretinin interneuron dendritic arbor complexity analysis at 7 
and 28 days after mild TBI. 
 
Calretinin interneurons were traced using Neurolucida software in order to 
investigate their dendritic morphology at 7 and 28 days post-injury. There was a 
significant decrease in total dendritic length in Calretinin interneurons located in the 
ipsilateral side in FPI mice compared to sham mice at 7 days post-injury (A, p<0.05). 
There were no differences in mean dendritic length found at 28 days post-injury 
between the same groups (B). Over time analysis of total dendritic length at 7 and 28 
days post-injury of FPI cortex contralateral and ipsilateral to the injury site at 7 days 
post-injury compared to cells found in the same regions at 28 days post-injury (C). 
Number of primary, secondary and tertiary dendrites of Calretinin interneurons at 7 
(D) and 28 days post-injury (E). Over time analysis of dendritic arbor complexity of 
Calretinin interneurons in the contralateral cortex (F) and the ipsilateral cortex (G) of 
sham mice and FPI mice. Soma size analysis of Calretinin interneurons in the cortex 
of sham and FPI mice at 7 or 28 days post-injury (H). Length analysis of primary, 
secondary or tertiary order processes of Calretinin interneurons at 7 or 28 days post-
injury in sham and FPI mice (I). Graphical representation of Calretinin interneurons in 
the ipsilateral cortex of sham and FPI mice at 7 days post-injury (J, K). Each 
concentric circle represents 10µm from the cell soma. Data are presented as mean ± 
SEM. Two-way ANOVA, followed by Bonferroni test *p<0.05, **p<0.01, ****p<0.0001.  
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Fig 3.6. Mild TBI results in a loss of inhibitory input to layer V pyramidal 
neurons 
 
Whole cell patch clamp recordings from layer V pyramidal neurons from sham and 
FPI mice were taken. During recordings neurons were filled with Neurobiotin and 
post stained to confirm their location in layer V and in the injury site. Representative 
image of layer V filled neurons after whole cell patch clamping (A, B). Example traces 
from sham and FPI mice showing mIPSCs (C). mIPSCs amplitude (Sham 12.74 ± 
0.68pA, FPI 13.50 ± 0.67pA) (D), frequency (Sham (n=8 cells from 5 animals) 1.46 ± 
0.25 Hz, FPI (n=12 cells from 8 animals) 0.68 ± 0.12 Hz) (E), and rise time (Sham 
4.34 ± 0.64ms, FPI 4.78 ± 0.71ms) (F), decay time (Sham 7.38 ± 0.95ms, FPI 13.32 
± 2.74ms)  (G) . Data are presented as mean ± SEM. Paired t-test **p<0.01. Scale 
bar= 100µm.  
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3.4. DISCUSSION 
 
Mild TBI can lead to cognitive and neuropsychiatric impairments in humans 
despite the absence of clear structural damage (Li et al., 2016). In this Chapter the 
investigations highlight that after a single mild brain injury a distinct mechanism of 
injury-induced neuronal plasticity in a discrete subpopulation of cortical interneurons 
is activated and is linked to decreased inhibitory input in pyramidal neurons.  
 
In this Chapter a Fluid Percussion Injury (FPI) device was used to induce a 
mild lateral brain injury in GAD67-GFP and Thy1-YFPH mice and investigate post-
injury alterations in interneurons. Mild injuries to the brain were confirmed by the lack 
of clear structural damage, absence of post-injury mortality and the short time 
required for mice to regain their righting reflex post-TBI (Thompson et al., 2005, Alder 
et al., 2011) (Table 3.1, Fig 3.1) . Lateral FPI is a well-characterized model of brain 
injury that reproduces key features of human TBI including focal contusion, 
subarachnoid hemorrhages, gliosis, neuronal loss and axonal injury (Dixon et al., 
1987, Hayes et al., 1987, Pitkanen and Immonen, 2014). 
Several studies have reported a deficit in GABAergic activity and loss of 
GABAergic interneurons in the hippocampus following various types of injury (Witgen 
et al., 2005, Mtchedlishvili et al., 2010, Pavlov et al., 2011, Almeida-Suhett et al., 
2015). There is also evidence that severe injuries induce changes in the total number 
of interneurons and in specific populations of interneurons in the cortex (Cantu et al., 
2015). However, alterations in the cortical inhibitory circuit after mild brain injury have 
not been previously evaluated. Therefore, in this Chapter, investigations aimed to 
quantify alterations in the population of interneurons after mild TBI. Results indicate 
that mild brain injury does not induce changes in the total number of interneurons or 
specific subpopulations of interneurons that reside in different layers of the cortex 
shortly after injury or as a delayed mechanism at later post-injury time points (Fig 
3.2). Moreover, there was no change in the number of Calretinin interneurons at any 
of the post-injury time points analyzed (Fig 3.3). Hence it was concluded that mild 
injury to the brain did not induce overall changes in the number of cortical GABAergic 
interneurons. 
Lateral FPI produces both focal and diffuse effects. The brain regions 
ipsilateral or under the injury site undergo most of the damage, while more distant 
parts of the brain, like the contralateral hemisphere, are usually not overtly affected 
(Peterson et al., 2015, Ostergard et al., 2016). It has previously been reported that 
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severe FPI can induce important reactive astrogliosis in the cortex characterized by 
low baseline levels in sham animals and the contralateral hemisphere and modest 
increases in trauma animals, peaking at 7 days and decreasing by 30 days post-
injury (Carbonell and Grady, 1999). In this Chapter cell proliferation in the cortex was 
evaluated as the presence of newly generated EdU+ cells and based on the 
literature, was used as an indication of a post-injury glial response (Chirumamilla et 
al., 2004, Rice et al., 2003, Susarla et al., 2014). It was determined that mild FPI 
induces cell proliferation under the injury site but not in other regions of the cortex, 
including the contralateral hemisphere. These results suggest more focal than diffuse 
damage after mild lateral FPI (Fig 3.4).  
 
Several studies have observed neurogenesis in rodents in response to 
moderate to severe traumatic brain injury (Dash et al., 2001, Rice et al., 2003, Blaiss 
et al., 2011, Cope et al., 2016, Wang et al., 2016). However, most studies have 
indicated that neurogenesis does not lead to neuronal replacement in the cortex 
(Salman et al., 2004, Blizzard et al., 2011). Since the focus of the current study is the 
inhibitory network the presence of newly generated cortical interneurons was 
evaluated. There was no induction of interneuron neurogenesis after injury indicated 
by the lack of EdU+ GFP+ and EdU+ CR+ neurons in the cortex. It was therefore 
concluded that despite notable cell proliferation, mild TBI evoked by lateral FPI in the 
mouse brain does not induce neurogenesis in the cortex (Fig 3.4). 
Previous studies have indicated that cortical GABAergic interneurons have 
the capacity to remodel their dendritic arbors under physiologically normal and 
pathological conditions (Lee et al., 2006, Lee et al., 2008, Blizzard et al., 2011, Chen 
et al., 2011). Moreover dendritic remodeling in cortical interneurons that express 
Calretinin was demonstrated in Chapter 2 using an in vitro model of transection 
injury. In this Chapter results indicate that mild FPI also induces morphological 
changes in Calretinin interneurons. Results showed that at 7 days post-injury 
Calretinin interneurons in the injury site had fewer secondary and tertiary processes 
when compared to the contralateral cortex and sham animals. However, those 
changes in dendritic arbor complexity were time dependent and were restored to 
sham levels by 28 days post-injury (Fig 3.5). During early post-natal development 
glutamate-mediated activity is essential for normal development of axonal and 
dendritic arbors in Calretinin interneurons (De Marco Garcia et al., 2011). Several 
studies have demonstrated an imbalance of excitation and inhibition shortly after 
injury (Ping and Jin, 2016) and increased glutamate levels (Hinzman et al., 2010, 
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Hinzman et al., 2012).  It is plausible that after mild brain injury Calretinin 
interneurons revert to a developmental stage where changes in excitation can 
promote changes in dendritic arbor complexity.  
Functional studies were carried out to determine if the morphological changes 
found in the subpopulation of Calretinin interneurons after mild brain injury could lead 
to functional alterations in the whole inhibitory circuit. For this purpose miniature 
inhibitory post-synaptic currents (IPSCs) were recorded from layer V pyramidal 
neurons. Recordings of the inhibitory activity or inhibitory afferents onto pyramidal 
neurons were used as an indication of the overall inhibitory network activity after 
injury (Cantu et al., 2014, Smith et al., 2015). Miniature IPSCs are spontaneously 
occurring events that reflect spontaneous, non action potential dependent release of 
GABA from individual presynaptic terminals of GABAergic interneurons (Cohen et al., 
2007). The frequency, amplitude, rise time and decay time of mIPSCs were 
calculated. Results indicated that at 7 days post-injury the average amplitude of the 
mIPSCs was equivalent between sham and FPI mice. The equivalent mIPSCs 
amplitude found between groups suggests that the surface expression of GABA 
receptors in layer V pyramidal neurons after injury was likely unaffected. Mild TBI 
was associated with a significant decrease in mIPSCs frequency. The observed 
decrease in mIPSCs frequency indicates that the number of inhibitory connections 
onto layer V pyramidal neurons in the injured cortex was potentially decreased at 7 
days post-injury (Fig 3.6).  
Similar results have been reported for granule cells and pyramidal neurons in 
the hippocampus after both mild and severe brain injury, at similar post-injury time 
points (Witgen et al., 2005, Mtchedlishvili et al., 2010, Almeida-Suhett et al., 2015). 
So far few studies have focused on exploring cortical inhibitory synaptic transmission 
after mild brain injury. Smith et al. reported no changes in layer V pyramidal neuron 
mIPSC frequency and amplitude in the prefrontal cortex after mild brain injury. The 
apparent discrepancy between this report and results in this Chapter may lay in the 
fact that the prefrontal cortex was not within the injury site in that study (Smith et al., 
2015). In the present investigation the alterations in inhibitory synaptic transmission 
were found in the injury site in the somatosensory cortex where the morphological 
changes in Calretinin interneurons dendritic arbors were observed. Moreover, the 
contrasting results might also reflect differences in neuroplasticity between the 
somatosensory cortex or barrel cortex and the prefrontal cortex (Erzurumlu, 2003, 
Medini, 2014, Sims et al., 2015).  
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Given that there were differences found between the sham and FPI groups in 
mIPSCs frequency but not mIPSCs amplitude, these results suggest that changes in 
inhibitory synapses onto layer V pyramidal neurons are predominantly presynaptic 
rather than postsynaptic, reflecting changes in the inhibitory network. A decrease in 
IPSCs frequency could be produced by either a decrease in the number of inhibitory 
synaptic afferents, or their efficacy onto the recorded cells, or a decrease in 
neurotransmitter release probability from these afferents, or a combination of both 
mechanisms. Although further experiments need to be carried out in order to 
determine the possible mechanism related to the decrease in mIPSCs frequency, 
previous studies in other regions of the brain, like the hippocampus, have determined 
that the IPSC pair pulse vesicle release is not affected after injury (Hunt et al 2011). 
Moreover there were no changes in mIPSCs kinetics (rise and decay time) indicating 
no changes in GABA receptor-subunit composition in the postsynaptic neuron further 
pointing to a presynaptic involvement (Hollrigel and Soltesz, 1997, Banerjee et al., 
2013).  
 
Calretinin interneurons represent approximately 10-30% of the total 
interneurons in the cortex (Markram et al., 2004). Even though this population of 
interneurons comprises a relatively small fraction of the total inhibitory neurons in the 
cortex, their unique connectivity and placement in the circuitry affords a large impact 
on inhibitory regulation as a whole (Dzaja et al., 2014). They have been described as 
being at the top of the interneuron hierarchy due to the fact that they preferentially 
regulate the activity of other interneuron populations (Barinka et al., 2015) and  
specifically target dendritic inhibitory interneurons to synchronize their activity (Caputi 
et al., 2009). This synchronization of dendritic inhibitory cells is a crucial process to 
provide effective inhibitory control of excitatory synaptic input of pyramidal cell 
dendrites (Toth and Magloczky, 2014). As a result Calretinin interneurons have a far-
reaching and wide influence on the whole cortical inhibitory circuit (Toth et al., 2010). 
It is therefore hypothesized that the post-injury dendritic remodeling of Calretinin 
interneurons, in terms of loss of secondary and tertiary processes, could result in 
less effective synchronization of dendritic inhibitory interneuron firing, leading to less 
effective inhibition of pyramidal neuron firing and ultimately resulting in a pathologic 
shift toward excess excitability. The changes described in dendritic arbor complexity 
of Calretinin interneurons were transient and reverted by 28 days post-injury. Further 
studies would need to be carried out in order to determine if the changes in inhibitory 
synaptic transmission found at 7 days post-injury are still present at a later time point 
when compensatory mechanisms seem to be activated to restore normal dendritic 
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complexity and possibly compensate for changes in synaptic input and reestablish 
normal excitatory/inhibitory balance. Furthermore future studies would be  aimed to 
investigate the possible behavioral and cognitive changes related to dendritic 
remodeling of Calretinin interneurons in mild TBI.  
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4. THE MICROTUBULE-STABILIZING DRUG EPOTHILONE D INCREASES 
AXONAL SPROUTING FOLLOWING TRANSECTION INJURY IN VITRO 	  
4.1 INTRODUCTION 
 
Axonal injury is a common consequence of traumatic brain injury (TBI).  
Axons are particularly vulnerable to injury as they project over long-distances and 
have a complex and highly organized structure (Meythaler et al., 2001, Johnson et 
al., 2012). After a traumatic brain injury the extent of damage is primarily determined 
by the severity of the initial injury. Although it is now recognized that even in the 
absence of initial axonal transection, and in seemingly mild forms of TBI, adverse 
axonal alterations occur at the level of the axon cytoskeleton (Smith et al., 2013). In 
particular, TBI can lead to cytoskeletal misalignment or loss, and the accumulation or 
compaction of cytoskeletal components which are hallmarks of neuronal 
degeneration (Maxwell, 1995). 
Microtubule alterations after injury include the loss of microtubule-associated 
proteins (MAPs) such as Tau and MAP2, (King et al., 2000, Farkas and Povlishock, 
2007, Bradke et al., 2012, Smith et al., 2013) and defects in axonal transport that 
lead to axonal swelling, the formation of axonal bulb structures, microtubule 
disconnection and ultimately axotomy (Smith et al., 1999, Tang-Schomer et al., 
2010). There is evidence to suggest that following brain injury, changes in 
microtubule dynamics are a critical component in the cascade of events that lead to 
reactive gliosis and the formation of the glial scar (Chuckowree and Vickers, 2003, 
Blizzard et al., 2011). However, microtubule reorganization has also been implicated 
in attempted axonal regeneration following injury, specifically the elaboration of 
sprouts into and across the lesion site (Blizzard et al., 2011, Sengottuvel and 
Fischer, 2011).  
The importance of microtubule deregulation in TBI pathology suggests that 
after injury, treatment with compounds that stabilize cytoskeletal microtubules can 
potentially modify multiple aspects of the brain’s response to trauma.  Microtubule 
stabilizing drugs, such as epothilones and taxanes, are widely used for cancer 
treatment and are now being investigated for their potential use in diseases of the 
nervous system.  At high concentrations these drugs hyper-stabilize microtubules 
and interfere with their normal breakdown, which is critical for cell division (Goodin et 
al., 2004, Kolman, 2005). However, at low concentrations these same drugs can 
stabilize microtubules enough to prevent their depolarization and dissolution, and 
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even encourage their polymerization.  This effect would be therapeutically significant 
for the treatment of the injured brain (Brunden et al., 2010, Hellal et al., 2011, 
Sengottuvel and Fischer, 2011, Baas and Ahmad, 2013). 
Paclitaxel, one of the taxanes, has been used in various animal models of 
nervous system trauma, and has been shown to promote axonal elongation and 
regeneration, reduce glial scar formation, and improve outcomes after nerve injury 
(Hellal et al., 2011, Sengottuvel et al., 2011). Despite these encouraging findings, 
Paclitaxel is not an ideal drug for the treatment of TBI due to poor blood–brain barrier 
(BBB) permeability, which prevents access of the drug to the CNS.  However 
Epothilone D (Epo D), a microtubule-stabilizing drug that competes with Paclitaxel for 
the binding site on β-tubulin, (Brunden et al., 2011) may be an excellent alternative.  
Epo D readily crosses the BBB and is retained within the CNS for several days 
(Wang et al., 2005b, Andrieux et al., 2006, Cortes and Baselga, 2007, Brunden et al., 
2012). It has been administered to mice carrying genetic mutations associated with 
familial Alzheimer’s disease and other related tauopathies, and was shown to 
compensate for the loss of tau function, improve axonal transport, reduce axonal 
dystrophy, decrease tau neuropathology, reduce neuronal loss and improve cognitive 
performance (Brunden et al., 2010, Barten et al., 2012, Lou et al., 2014).  The 
beneficial effects of Epo D observed in these studies, coupled with the vital BBB 
penetration, suggest that this drug holds considerable promise as a potential 
therapeutic strategy for the treatment of TBI.   
In this Chapter the effect of Epo D on the post-injury axonal sprouting 
response of cultured neurons was examined. Epo D was found to induce a 
regenerative response in neurons subjected to an in vitro model of CNS trauma. 
Results from this Chapter indicate that Epo D could find therapeutic efficacy in TBI, 
tackling the brain’s inability to repair following injury by promoting the regeneration of 
neuronal sprouts, although further investigations using in vivo animal models of injury 
are necessary.  
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4.2. MATERIALS AND METHODS 	  
 
4.2.1. Wild type and transgenic mice 
All experimental procedures involving animals were approved by the Animal 
Ethics Committee for animal experimentation of the University of Tasmania and were 
performed in accordance with the Australian Code of Practice for the Care and Use 
of Animals for Scientific Purposes (A0011952). C57BL/6 wild type and Thy1-YFP 
transgenic mice were used for experiments. Animals were housed in individually 
ventilated cages, maintained at ~20oC, on a 12 hour light/dark cycle, with access to 
food and water ad libitum.  
4.2.2. Cell culture 
Primary dissociated cortical neuron cultures were prepared from mouse 
embryos as previously described (Dickson et al., 2000). Briefly, C57BL/6 and Thy1-
YFP transgenic mice were time-mated, the pregnant females killed by CO2 exposure 
at 15.5 days of gestation, and the embryos removed.  Embryos were genotyped by 
fluorescence imaging using 470nm light on a Carestream Image station 4000MM pro 
(Carestream Molecular Imaging, USA).  Neocortical hemispheres were dissected into 
5 ml Hanks Buffered Salt Solution (HBSS; Thermo-fisher Scientific, USA).  Cortical 
tissue was dissociated by enzymatic digestion (0.025% w/v Trypsin, 5 minutes, 
370C), which was halted by the addition of 1 ml of pre-warmed medium 
[NeurobasalTM supplemented with 2% v/v B27, 10% v/v fetal calf serum, 0.5mM L-
glutamine, 25µM glutamate and 1% streptomycin penicillin; Thermo-fisher Scientific, 
USA]. Tissue pieces were allowed to settle and after removal of the medium, 
dissociation was completed by resuspension of the cells in 500µl of pre-warmed 
medium and gentle trituration.  Cell viability and concentration was assessed using 
trypan blue vital dye exclusion and 3.5 x 104 cells/mm2 were plated per 19mm 
diameter glass coverslip (Marienfeld, Germany).  Each coverslip was pre-coated with 
0.001% Poly-L-lysine (Sigma-Aldrich, USA) in 0.01M PBS (pH 7.0). 
 
Cultures were maintained in a 37°C humidified atmosphere of 5% CO2 for up 
to 15 days.  At 1 day in vitro (DIV) the medium was removed and replaced with 
serum-free growth medium [NeurobasalTM, 2% v/v B-27 supplement, 0.5 mM L-
glutamine, and 1% streptomycin penicillin; Thermo-fisher Scientific, USA], after which 
time ~50% of the medium was replaced every 3–4 days.  
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4.2.3. Axonal transection and pharmacological treatment of cortical neurons 
Axonal transection was carried out using a Barkan goniotomy knife (Kaisers, 
Germany) on cortical cultures at 15 DIV (Blizzard et al., 2013). One long injury that 
extended the full diameter of the coverslip was made, ensuring complete axonal 
transection and producing a cell free lesion of ~50-150µm wide.  Primary cultures 
were immediately treated with 0.1nM, 1nM, 10nM or 100nM Epo D or 
dimethylsulphoxide (DMSO; Sigma) alone, which acted as a vehicle control.  Twenty-
four hours after treatment, cells were fixed for 30 minutes with 4% (w/v) (PFA) in 
(PBS).  Each treatment was performed on four replicate coverslips. Analysis was 
performed in four replicates across three independent experiments.  
4.2.4. Cell viability assays 
The Alamar blue (Invitrogen) assay, an indicator of cellular metabolic activity, 
was used to measure the viability of cultured neurons after drug treatment. Cells 
were grown at a density of 2 x105 cells/mm2 in 96 well plates.  At 15 DIV they were 
treated with increasing concentrations of Epo D.  24 hours after treatment cells were 
washed three times with NeurobasalTM medium and incubated for 4 hours at 37°C 
with a 10% (v/v) dilution of Alamar blue in serum-free growth medium. Fluorescence 
was detected using a Fluostar optima automated plate-reading fluorometer (BMG 
labtech), set to 540nm excitation and 590nm emission detection, and analysis was 
performed in triplicates on three independent experiments.  
Quantification of pyknotic nuclei was performed on cultured neurons fixed 
with 4% (w/v) paraformaldehyde (PFA) in phosphate buffered saline (PBS).  Neurons 
were stained with the fluorescent DNA-binding dye 4′,6-diamidino-2-phenylindole 
dihydrochloride (DAPI) (Invitrogen, Life technologies, USA) at 1:1000 dilution in PBS 
for 15 minutes at room temperature.  Neurons with condensed or fragmented nuclei 
were considered pyknotic.  Two hundred cells were counted per culture, and a 
minimum of four independent cultures analyzed per treatment condition. 
4.2.5. Western blot analysis 
Cortical neurons were grown on 12 well plates at a density of 5 x 105 
cells/mm2.  At 15 DIV neurons were treated with 0.1nM Epo D, 100nM of Epo D, or 
DMSO for 90 minutes or 24 hours.  Cultures were subsequently washed 3 times in 
warmed serum-free medium and placed on ice.  The serum-free medium was 
removed and 150 µL of cell lysis buffer [50 mM Tris-HCl, 150 mM NaCl, 16 mM 
nonyl phenoxypolyethoxylethanol-40 (NP-40), 24 mM Sodium deoxycholate, 3.5 mM 
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SDS, and one protease inhibitor tablet (Roche Diagnostics Pty Ltd, Australia) 
containing Trichostatin A (TSA; 1:10000, Sigma)] was added to each well.  Cells from 
each well were scraped, transferred to a 1.5ml microcentrifuge tube and centrifuged 
at 13,000 RPM 4°C for 10 minutes (Hermle Z160M, Hermle Labortechnick, 
Germany).  The supernatant was removed and the protein content quantified using a 
Bio-Rad-DC assay in microplate format (Bio-Rad Pty Ltd, Australia).  
 
Samples were diluted in Laemelli sample buffer (Bio-Rad, New Zealand), 
vortexed, and heated to 90°C for 10 minutes.  The samples were next separated on 
a 12% SDS-PAGE gel by sodium dodecyl sodium sulfate polyacrylamide gel 
electrophoresis at 100V for 60 minutes and 150V for 20 minutes.  Proteins were 
electrophoretically transferred to nitrocellulose membranes at 80V for 60 minutes at 
4°C and blotted with antibodies against Acetylated-tubulin (1:5000; Sigma-Aldrich), 
Tau (1:5000; Dako), and GAPDH (Glyceraldehyde 3-phosphate dehydrogenase; 
1:10000, Merck Millipore) diluted in TBST (TBS, 0.05% v/v Tween- 20) containing 
5% w/v skim milk powder and 0.05% v/v Tween-20, overnight at 4°C.  After washing 
three times for 10 minutes in TBST, membranes were incubated with peroxidase-
conjugated secondary antibodies diluted in TBST (1:5000, Dako, anti-rabbit HRP, 
anti-mouse HRP) for 90 minutes at room temperature.  The chemiluminescent signal 
was developed using the Immobilon Western Chemiluminescent HRP Substrate 
(Merk Millipore) according to the manufacturer’s instructions, and detected using a 
Chemi-Smart 5000 instrument (Vilber Lourmat, France).  Images were analyzed 
using ImageJ 1.46.  Experiments were performed in triplicates.  
4.2.6. Immunocytochemistry  
Cultures at 15 DIV that were either untreated, or injured and exposed to Epo 
D or DMSO for 24 hours were fixed in 4% w/v PFA in PBS prior to immunolabeling.  
Primary antibodies used included rabbit anti-Tau (1:10,000; Dako); rat anti-green 
fluorescent protein to label YFP (1:3,000; Nacalai tesque); and rabbit anti-
synaptophysin (1:1000; Millipore), diluted in 0.3% v/v Triton-X100 (Fluka) in PBS, 
and applied for 1 hour at room temperature followed by overnight incubation at 4°C.  
Coverslips were washed thrice in PBS before the application of isotype- and species-
specific secondary antibodies. Secondary antibodies [Alexa Fluor® 594- and 
AlexaFluor® 488- conjugated goat anti-rat and goat anti-rabbit IgG H+L (Invitrogen)] 
were diluted 1:1000 in 0.01M PBS and applied to coverslips for 2 hours at room 
temperature.  Coverslips were washed thrice with PBS before mounting in 
fluorescent mounting medium (Thermo scientific, USA).  Immunolabeling was 
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visualized and imaged using a DMLB2 upright fluorescent microscope (Leica, 
Germany) or UltraView Spinning disk confocal microscope with Velocity Software 
(Perkin Elmer, USA). 
4.2.7. Live cell imaging 
Cells were grown in custom-made poly dimethylsiloxane (PDMS) chambers 
placed over 22 mm x 22 mm poly-L-lysine coated glass coverslips, and plated at a 
density of 1.5x105 cells/mm2.  Axonal transection was carried out using a Barkan 
goniotomy knife and treated with Epo D or DMSO (as described above).  Cultures 
were imaged at 37°C, at a rate of 1 image every 10 minutes for a period of 24 hours 
using a Nikon TiE motorized inverted microscope with x40 / 0.95 objective.  Each 
PDMS chamber contained 3 to 4 openings allowing injured cultures that were drug 
treated, and those that were vehicle treated, to be imaged during the same imaging 
session.  Neurite growth rate and length was calculated using DIC images of post-
injury neurites growing into the injury site, and Nikon NIS-elements AR 3.2 software 
(Nikon Instruments INC, USA).  
4.2.8. Statistical analysis 
All statistical analysis was performed in Graph-pad Prism version 6.04 
(Graph-pad Software Inc., CA).  Comparisons were made using a one-way ANOVA 
or Two-way ANOVA with Bonferroni post-hoc test or Student’s t-tests as specified.  
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4.3. RESULTS 
 
4.3.1. Cortical neuron development in vitro 
Cortical neurons derived from Thy1-YFP transgenic mice were grown on 
poly-L-lysine coated coverslips, and in the days after plating, developed and 
extended neurites as previously described (Dotti et al., 1988). The morphological and 
histological characteristics of the neurons at 7 and 15 DIV were analyzed to 
characterize maturation. By 7 DIV neurons had extended long processes and had 
made contact with several other cells in the culture (Fig 4.1).  However, by 
immunocytochemistry it was determined that the expression of the vesicular synaptic 
marker synaptophysin was minimal and diffuse (non-punctate) and found in the cell 
bodies and neurites (Fig 4.1 A-C).  This expression pattern is indicative of neurons 
that are immature and have not formed synapses.  In contrast, neurons cultured for 
15 DIV were not only more complex, with multiple processes contacting surrounding 
cells, but the synaptophysin staining had become punctate and extended along the 
dendritic shafts (Fig 4.1 D-F).  This pattern of staining is consistent with the synaptic 
expression of synaptophysin (Thiel, 1993).  
4.3.2. Cell viability after drug treatment 
To determine the concentrations of Epo D that were safe and efficacious the 
effect of Epo D addition on the viability of cultured cortical neurons was examined.  
The effect of Epo D on neuron viability was assessed using two different methods.  
The first examined the number of pyknotic nuclei in the culture, identified by nuclear 
morphology following DAPI staining (Fig 4.2 A-D).   The percentage of neurons with 
pyknotic nuclei was equivalent between vehicle- and Epo D-treated cultures, being 
~35% in vehicle-treated cultures and ranging from ~32% to ~40% for cultures 
exposed to a range of Epo D concentrations (Fig 4.2 E).   
The second viability assay employed, utilized the fluorogenic redox indicator 
dye, Alamar blue. This dye becomes fluorescent upon reduction by mitochondrial 
enzymes and is an indicator of the metabolic activity of viable cells (Rampersad, 
2012). The fluorescence intensity of vehicle- and Epo D-treated cultures was 
assessed and found to be equivalent (Fig. 4.2 F).  Therefore neuron viability was 
unaffected by Epo D exposure at any of the concentrations trialed. 
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Figure 4.1. Development of Thy1-YFP cortical neurons in vitro.  
To examine neuronal characteristics, dissociated YFP positive neurons were grown 
as a monolayer on a poly-L-lysine substrate. 7 DIV (A), 15 DIV (D) YFP labeling 
(green). 7 DIV (B), 15 DIV (E) labeling for the synaptic vesicle marker synaptophysin 
(red). 7 DIV(C), 15 DIV (F) double labeling for YFP and synaptophysin.  At 7DIV 
double labeling for YFP and synaptophysin indicated that YFP was present 
throughout cell bodies and processes while there was minimal immunoreactivity for 
synaptophysin (C). At 15 DIV there was an increased immunoreactivity for 
synaptophysin (red) and there was a colocalization of synaptophysin and YFP in 
punctate positions lateral to dendrite shafts (F).  Scale bar = 14 µm.  
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Figure 4.2. Cell viability after Epo D treatment.  
Representative images of YFP positive neurons in culture at 15 DIV after vehicle 
treatment (A) or 100nM Epo D treatment (C).  DAPI staining of 15 DIV neurons after 
vehicle treatment (B) or 100nM Epo D treatment (D). DAPI staining was used to 
evaluate the number of pyknotic cells; cells brightly stained with condensed and 
fragmented nuclei were considered pyknotic (Inset: apoptotic nuclei, arrow and 
normal nuclei, arrowhead). Bar graphs demonstrating the effect on cell viability of 
exposing cultures to Epo D for 24 hours. DAPI staining, evaluation of the percentage 
of pyknotic cells after drug treatment (E). Alamar blue fluorescence intensity was also 
used to assess neuronal viability (F). Fluorescence intensity was expressed as 
percentage of the control treatment. One-Way ANOVA followed by Bonferroni test. 
Data are presented as mean ± SEM . Scale bar=50µm.  
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4.3.3. Evaluation of Epo D effects on microtubule stabilization  
To determine the efficacy of Epo D on microtubule (MT) stabilization in uninjured 
cortical neurons in vitro, the effect of Epo D treatment on the expression of a 
biomarker of MT stabilization, tubulin acetylation was investigated (Brunden et al., 
2011). After 90 minutes of exposure to 0.1nM Epo D, cultured neurons were found to 
express the same level of acetylated tubulin as vehicle-treated control cultures (Fig 
4.3 A). However treatment with 100nM Epo D resulted in a significant increase in the 
level of acetylated tubulin when compared to vehicle (p=0.039, ANOVA, n=3 
cultures), which is suggestive of increased microtubule stabilization with high 
concentrations of the drug. There was no significant increase in acetylated tubulin in 
response to either concentration of Epo D when cultures were treated for 24 hours 
(Fig 4.3 B). 
In order to determine whether the transient change observed in acetylated 
tubulin expression following Epo D treatment correlated with a change in Tau-protein 
expression, and to gain insight into the mechanism of action of the drug the influence 
that Epo D addition to cortical neurons exerted on total Tau protein levels was 
examined.  After 90 minutes of treatment there was no change in the level of Tau 
protein expressed by cortical neuron cultures, when comparing Epo D- with vehicle-
treated control neurons (Fig 4.3 C).  However following 24 hours of exposure to 
100nM Epo D, there was a significant decrease in total Tau protein levels (Fig 4.3 D; 
p<0.01, ANOVA, n=3).  Therefore it was concluded that cortical neurons respond to 
100nM Epo D treatment in the short-term by transiently increasing their expression of 
acetylated tubulin, which is indicative of stabilized microtubules.  However sustained 
exposure to the drug for 24 hours reduced Tau protein levels.  
 
4.3.4. Epo D modulates post-injury sprout outgrowth 
Having demonstrated that Epo D can modulate tubulin stabilization, the effect of this 
microtubule stabilization on post-injury axonal sprouting response was investigated 
next.  Cultures were grown for 15 DIV, to reach a state of relative maturity, before 
they were subjected to axonal transection.  Epo D or vehicle was immediately added 
to the injured cultures, which were fixed 24 hours later for immunocytochemistry.  
Previous studies have indicated that 24 hours post-injury is the optimal time to 
evaluate sprouting, as this is when it is maximal (Chuckowree and Vickers, 2003, 
Blizzard et al., 2013). Tau immunolabeling revealed that Epo D exposure had a 
substantial effect on post-injury axonal sprouting.   
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Figure 4.3. Evaluation of Epo D effects on acetylated tubulin and Tau levels.  
15 DIV cortical neurons were treated for 90 minutes and 24 hours with two doses of 
Epo D (0.1nM-100nM). Immunoblot and densitometry analysis of acetylated tubulin 
(Ac-Tub) (55kDa) and loading control GADPH (37kDa) 90 minutes post Epo D 
treatment (A) and 24 hours post drug treatment (B). Immunoblot and densitometry 
analysis of Tau (45-65 kDa) and GADPH at 90 minutes post Epo D treatment (C) and 
24 hours post Epo D treatment (D). Data are presented as mean ± SEM . One way 
ANOVA, followed by Bonferroni test *p<0.05, **p<0.01. 
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In vehicle-treated cultures there was axonal sprout outgrowth into the injury 
site 24 hours after injury (Fig 4.4 A), and this appeared to be modulated by Epo D-
treatment (Fig 4.4 B-D).  The number of sprouts identified and quantified within the 
injury site was normalized to a 100µm length of injury and subtracted from vehicle.  
On average ~1.3 sprouts were extended into the injury site by vehicle treated 
cultures, whereas Epo D-treated cultures produced ~3 and ~2.7 sprouts per 100µm 
of injury site when exposed to 0.1nM and 1nM of Epo D, respectively (Fig 4.4 E; 
P<0.001 and p<0.05, ANOVA, n=3 independent experiments).  Despite the larger 
number of sprouts generated by Epo D-treated cultures, there was no change to 
average sprout length (Fig 4.4 F).  Consistent with the finding that 100mM of Epo D 
affected microtubule stabilization, this same dose significantly reduced sprout 
outgrowth following 24 hours of treatment (Fig 4.4 D-E; ANOVA, p<0.05), as cultures 
extended only ~0.5 sprouts per 100 µm of the injury site.  These results indicate that 
Epo D can modulate the post-injury sprouting response in a dose dependent manner.  
 
As the previous western blot analysis had revealed that 100nM of Epo D 
could decrease Tau protein levels within 24 hours, it was assessed whether axonal 
sprouts, extending into the injury site, were in fact Tau immunolabeled.  Results 
indicate that all axonal sprouts found after 24 hours of drug treatment with 100nM of 
Epo D are positive for Tau (data not shown). 
To determine whether Epo D was promoting axon sprouting by excitatory 
projection neurons in vitro, the effect of Epo D treatment on post-injury axonal 
sprouting was studied in a specific subpopulation of principal or projection neurons. 
For this purpose, neurons expressing YFP under the control of the neuron-specific 
Thy1 promoter were specifically examined.  Neurons from Thy1-YFP transgenic mice 
were grown to relative maturity, and were injured using the complete transection 
method at 15 DIV.  Cultures were treated with vehicle or Epo D for 24 hours.  YFP-
expression within the neurites allowed us to specifically detect YFP-positive spouts 
within the injury site (Fig 4.5 B).  These sprouts were also Tau positive, indicating 
they were axons (Fig 4.5 A, C).  Quantitative analysis of post-injury sprouting showed 
that 0.1nM Epo D significantly increased the number of YFP-positive sprouts 
elaborated into the injury site (0.58 ± 0.05 sprouts) compared to vehicle (0.28 ± 0.02 
sprouts) (Fig 4.5 D).  Epo D treatment did not affect mean sprout length of YFP-
positive sprouts (Fig 4.5 E). These data indicate that the response of YFP+ projection 
neurons to Epo D-treatment is consistent with the response of the total neuronal 
population represented by Tau-positive sprouts, demonstrating the Epo D can 
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broadly modulate the sprouting response of multiple neuron types.     
4.3.5. Epo D does not influence the rate of post-injury sprout extension 
Having established that Epo D could successfully increase the total number 
of sprouts elaborated, whether the drug was influencing the rate at which neurons 
extended these processes into the injury site was explored next. Two concentrations 
of Epo D (0.1nM and 100nM) based on their ability to significantly influence sprout 
outgrowth were examined (Fig 4.6).  Cells were cultured in custom-made chambers 
for 15 days before transection injury.  Immediately after injury cells were treated with 
vehicle or Epo D, and time-lapse movies were collected over the following 24 hours.  
As observed previously, neurites grew into the injury site under all conditions (Fig 4.6 
A-C). The mean velocity of sprout outgrowth in vehicle-treated and Epo D-treated 
cultures was calculated, and found this to be comparable between treatments (Fig 
4.6 D). It was also determined that Epo D treatment had no significant effect on the 
maximal speed of sprout outgrowth (Fig 4.6 E).  
Since the previous results indicated that Epo D treatment had no significant 
effects on post-injury sprout length at 24 hours post-injury, it was next investigated if 
drug treatment could affect sprout length at different time points after injury. Using 
live imaging sprout length was examined after drug treatment during a 24 hour post-
injury time period.  As with previous results, sprout length was not significantly 
affected by drug treatment at any of the time points analyzed (Two-way ANOVA, 
p>0.05), although there was a trend towards reduction of sprout length with 100nM 
Epo D and increased sprout length with a low concentration of the drug of 0.1nM (Fig 
4.6 F). 
In summary these results show that moderate stabilization of microtubules 
can modulate the growth ability of neurons in culture.  
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Figure 4.4. Tau immunofluorescence labeling demonstrating the effect of Epo 
D exposure on post-injury axonal sprouting at 15 DIV.  
24 hours post-injury the sprouting response was extensive and several sprouts had 
crossed the lesion site in vehicle treated cultures (A). Cultures treated with 0.1nM 
Epo D (B) and 1nM Epo D (C) showed an increased number of sprouts in the injury 
site, while cultures treated with 100nM Epo D (D) had a decreased number of post-
injury sprouts relative to vehicle. Bar graphs represent the mean number of Tau 
positive sprouts per 100 µm of injury site length normalized to vehicle (E). Mean 
post-injury sprout length (F). Data are presented as mean ± SEM . One way ANOVA, 
followed by Bonferroni test *p<0.05, **p<0.01. Scale bar = 50 µm. 
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Figure 4.5 Number and mean length of Thy-1 YFP positive sprouts within the 
injury site after Epo D treatment.  
Tau (A) YFP labeling (B) of post-injury sprouts. Colocalization of Tau and YFP (C). 
Bar graph showing mean number of YFP positive sprouts per 100 µm of injury site 
length normalized to vehicle at 24 hours post-injury (D). Bar graph showing mean 
sprout length of YFP immunopositive sprouts at 24 hours post-injury and drug or 
vehicle treatment (E). Error bars are SEMs. One way ANOVA, followed by Bonferroni 
test *p<0.05. Data are presented as mean ± SEM. Scale bar = 40µm, for inset 20µm. 
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Figure 4.6. Post-injury sprout dynamics after Epo D treatment.  
Live imaging of post-injury sprouts over a 40 minutes period of vehicle treated 
sprouts (A), 0.1nM Epo D treated sprouts (B), and 100nM Epo D treated sprouts (C).  
Bar graphs demonstrating the effect of Epo D treatment on post-injury spout growth 
velocity. Mean sprout growth velocity (D). Maximal sprout growth velocity (E). There 
were no significant differences in sprout growth velocity or maximal sprout growth 
velocity after drug treatment compared with control. Error bars are SEMs. One-way 
ANOVAa, followed by Bonferroni test. Time-lapse analysis of mean sprout length 
after drug treatment (F). There were no significant differences in sprout length at any 
of the time points analyzed after drug treatment. Two-way ANOVA multiple 
comparisons. Data are presented as mean ± SEM . Scale bar= 10 µm 
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4.4. DISCUSSION 
 
Plasticity and regeneration of the mature CNS after trauma has been 
demonstrated in various models of injury such as stroke or focal and general 
structural brain injury (Chen et al., 2002, Carmichael, 2003, Blizzard et al., 2011, 
Canty et al., 2013). It has been well described that mature cells respond to injury with 
a substantial regenerative attempt indicated by the elaboration of sprout-like 
protuberances into the injury site (Chuckowree et al., 2004, Wieloch and Nikolich, 
2006). To date, the beneficial outcomes of neuronal regeneration within the injury 
site in vivo are limited, as regenerative sprouts rarely result in functional recovery, 
and may result in aberrant non-functional axonal connectivity (McKinney et al., 1997, 
McKinney et al., 1999). Thus it is imperative to devise techniques targeted at 
manipulating the regenerative response of injured neurons.  In this study, primary 
cortical neurons were grown to relative maturity and the effects of the microtubule-
stabilizing drug Epo D on the post-injury axonal sprouting response were 
investigated. Using immuno-fluorescence-labeling and live imaging techniques, it 
was found that Epo D affects the number of sprouts elaborated into the injury site in 
a concentration dependent manner, without affecting the rate of growth of this 
sprouting response.  
When studying cortical neurons in vitro it is extremely important to ensure that 
neurons model many key characteristics of the in vivo system. For the particular 
investigations presented here, it was of great importance to determine maturity of 
pyramidal neurons in vitro since previous investigations have demonstrated that the 
neuronal response to injury is dependent on neuronal maturity (Chuckowree and 
Vickers, 2003, Blizzard et al., 2007). Development of primary murine cortical neurons 
in vitro occurs via a sequence of steps across a defined time-course, involving 
neurite outgrowth, polarization and elongation followed by loss of immaturity markers 
such as growth cone markers and localization of synaptic proteins in dendritic spines 
as an indication of mature synapses (Dichter, 1978, Dotti et al., 1988, De Lima et al., 
1997, Picken Bahrey and Moody, 2003). Neuronal development in culture in this 
study was assessed by the use of morphological, synaptic and electrophysiological 
characteristics (See Chapter 2). It was demonstrated that cortical neurons take 
approximately 2 weeks to mature to the stage where they form complex neuronal 
networks with multiple connections, have synaptophysin expression characteristic of 
functional synapses and fire action potentials (See Chapter 2).  This developmental 
time-course of cortical neurons in vitro mirrors that of their in vivo development, 
where neurons in the cortical plate have been demonstrated to gain repetitive firing 
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ability by postnatal day 14 (Picken Bahrey and Moody, 2003). 
This study determined the role that Epo D manipulation of microtubule 
stabilization plays in regeneration. Epo D has been shown in vivo to promote 
polymerization of tubulin heterodimers into microtubules and stabilize pre-formed 
microtubules, and has recently generated interest as a potential candidate for 
protection from neurodegeneration (Andrieux et al., 2006, Brunden et al., 2010, 
Brunden et al., 2011, Barten et al., 2012, Cartelli et al., 2013).  However, Epo D is 
most commonly used as a drug in cancer therapy, (Wang et al., 2005a) where it 
exerts it action by binding to tubulin and causing a microtubule-mediated obstruction 
of mitosis and cell division, producing an arrest of cell growth or apoptosis (Cortes 
and Baselga, 2007, Cheng et al., 2008). The results show that Epo D had no 
significant effects on neuronal viability, metabolic function or cellular health when 
applied directly to neurons, at any of the concentrations applied.  This indicates that 
cortical neurons are capable of tolerating up to 100nM of Epo D with no evident 
negative consequences on neuronal viability.  Supporting the results presented here, 
previous research has shown that the use of Epo D in the treatment of 
neurodegenerative diseases requires a lower concentration of active drug for efficacy 
than the concentrations used for cancer therapy, and that no side effects are found in 
mice treated with systemic low doses of the drug (Beer et al., 2007, Brunden et al., 
2010, Barten et al., 2012, Brunden et al., 2012, Fournet et al., 2012). 
To determine the effect of Epo D on microtubule dynamics in cultured 
neurons, tubulin acetylation, and total Tau levels were investigated.  Tubulin 
acetylation is a widely used marker of stable polymerized microtubules, with α-tubulin 
becoming acetylated at lysine-40 within stable microtubules, and conversely α-tubulin 
becoming rapidly deacetylated within non-polymerized microtubules (Conde and 
Caceres, 2009, Janke and Kneussel, 2010).  This data indicates that relatively low 
doses of Epo D, such as 0.1nM, are sufficient to increase axonal sprouting, but are 
unable to alter tubulin acetylation within 90 minutes or 24 hours of application.  In 
contrast results demonstrate that 100nM Epo D treatment, which significantly 
decreases the axonal sprouting response at 24 hours post treatment, causes a 
significant initial rise in acetylated tubulin that is resolved by 24 hours.   
The effects of Epo D on total protein Tau level was also investigated.  Tau is 
a microtubule-associated protein (MAP) that has been demonstrated to be an 
integral component of axon formation and neuronal transport, and can serve as a 
substrate for several cellular signaling pathways (Tytell et al., 1984).  Results 
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presented in this Chapter indicate that 100nM of Epo D produces a significant 
decrease in Tau levels at 24 hours post treatment.  Since Tau is known to stabilize 
microtubules, (Drechsel et al., 1992) these data suggest that prolonged high dose 
Epo D exposure effectively destabilizes microtubules, giving some indication that a 
prolonged exposure to a high concentration of the drug could produce negative 
consequences and needs further investigation.  Similar findings were previously 
reported in Paclitaxel trials.  It has been demonstrated that Paclitaxel can 
significantly reduce total Tau levels and Tau mRNA in a dose-dependent manner, 
and can also affect the amount of Tau incorporated into microtubules (Kar et al., 
2003, Dickey et al., 2006).  A relatively low dose of Epo D (0.1nM), on the other 
hand, did not significantly alter acetylated tubulin or Tau levels at either 90 minutes 
or 24 hours following application indicating that this dose of Epo D did not drive the 
stabilization of microtubules but rather promotes polymerization.  Therefore, the 
results presented here provide compelling evidence to support the notion that Epo D 
targets microtubules and can increase microtubule stabilization (Barten et al., 2012).  
 
To investigate drug effects on post-injury sprouting, mature cultures were 
injured using an established scratch model of injury.  This in vitro model of complete 
transection injury is capable of eliciting substantial axonal sprouting at 24 hours post-
injury.  Whilst this injury is unable to replicate the complexity of the injured brain, it is 
a powerful tool for investigating drug effects on neuronal regeneration, screening for 
treatment targets and identifying new injury biomarkers (Chung et al., 2002, 
Chuckowree and Vickers, 2003, Loov et al., 2013). In this study Epo D was added to 
the culture media immediately after transection injury.  The administration of a high 
concentration of Epo D (100 nM) resulted in a substantial reduction of the axonal 
sprouting response by approximately 50%, in respect to vehicle.  This suggests that 
the stabilization of microtubules, evidenced by the initial increase in acetylated 
tubulin and loss of Tau reduces the number of axons that are able to respond to 
injury with the formation of axonal sprouts.  Conversely, the administration of lower 
concentrations of the drug (0.1nM, 1nM) significantly increased the number of Tau 
immunolabeled sprouts directed into the injury site.  These data indicate that Epo D 
promotes polymerization but not stabilization of microtubules, and increases the 
ability of neurons to regenerate.   
 
Tau pathology in TBI has been demonstrated in animal models and in human 
studies (Ojo et al., 2013, Ojo et al., 2016, Puvenna et al., 2016). Given the drug’s 
effects on tau demonstrated in this study and previous evidence indicating that there 
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are beneficial effects of epothilone treatment in a range of tauopathies,  it is plausible 
that Epo D treatment in TBI might improve outcomes after injury not only by 
modulating axonal plasticity through microtubule stabilization but also by 
compensating for the possible loss of function of tau present after injury.  
 
Previous studies in Chapter 2 have indicated that subtypes of CNS neurons 
respond differently to injury (Blizzard et al., 2011). Consistent with results from Tau 
immunolabeled axonal sprouts, 24 hours post-injury Epo D treatment on neurons 
derived from mice expressing YFP under the Thy1 promoter pyramidal neurons 
resulted in a significant increase in the number of sprouts into the injury site.  This 
implies that the microtubule manipulation of the post-injury response is important for 
subpopulations of pyramidal neurons.    
No significant effect of Epo D on sprout outgrowth speed or mean sprout 
length was found.  Previous studies indicate that Paclitaxel can promote axonal 
elongation in the injured optic nerve, and can increase elongation of dorsal root 
ganglion (DRG) neurons after spinal cord injury (Hellal et al., 2011, Sengottuvel et 
al., 2011). The data presented in this Chapter suggests that in an isolated system of 
cortical neurons, rate of outgrowth may not be reliant upon microtubule dynamics. 
However, it has been reported that the regenerative response of cut axons is 
correlated with the length of the remaining stump (Gomis-Ruth et al., 2008, Cengiz et 
al., 2012). Thus it is plausible that by using the scratch injury model where numerous 
axons are severed at once (added to the fact that the length of post-injury sprouts 
was only measured in the cell free scratch area), could have a confounding effect 
possibly masking a drug influence on post-injury sprout length and outgrowth speed.  
The CNS response to injury is complex, involving a multifaceted sequence of 
events that plays out over a broad time course.  Due to this complexity, it remains 
unclear whether regenerative sprouting is beneficial or detrimental (Cafferty et al., 
2008b). Experimental models have demonstrated that neuronal regeneration and 
plasticity can lead to improvements in functional outcomes (Rossignol et al., 1999, 
Weidner et al., 2001, Bareyre et al., 2004). However other models suggest that post-
injury sprouting may result in aberrant axonal connectivity, possibly contributing to 
the development of epilepsy post-injury (Prince et al., 2009, Hunt et al., 2013). This 
leads to the notion that axonal regeneration may be advantageous in one facet and 
then deleterious in another. In this regard, the opposing effects of low and high doses 
of Epo D on post-injury sprouting could be beneficial.  A drug that could control 
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neuroplasticity in a dose dependent manner could be of great importance as a 
therapeutic intervention. Further studies would need to focus in elucidating the 
optimal timing of drug delivery to ensure treatment with different concentration of the 
drug are given are at the right time during the progression of the disease to ensure 
beneficial outcomes.  
A further pathological characteristic of the neuronal response to injury is the 
formation of focal axonal swellings, known as axon bulbs, either at the end of a 
completely axotomised axon or as a swelling in an intact injured axon (Maxwell, 
1995, Meythaler et al., 2001, Smith et al., 2013, Hanell et al., 2014). Such axonal 
bulbs, present in both grey matter and white matter tracts in the injured brain, are 
associated with a disruption in axonal transport, which is mediated by microtubules 
(Maxwell, 1995, Erturk et al., 2007, Tang-Schomer et al., 2012). Although not the 
focus of the current investigation, determining the effect of Epo D’s manipulation of 
microtubules on the formation and persistence of axonal bulbs following injury is an 
intriguing avenue for future investigations.  
The findings of the current study have important implications for the 
understanding of Epo D as a possible therapeutic intervention for TBI.  Unlike 
Paclitaxel, Epo D can penetrate the BBB making it an ideal candidate as a potential 
therapeutic.  The data presented here support cortical neurons being able to tolerate 
relative high concentrations of Epo D, and indicate that this drug can increase 
microtubule stabilization by increasing tubulin acetylation. The results show that at 
relative high doses Epo D can discourage neuronal sprouting, and at low doses it 
promotes polymerization of microtubules while maintaining dynamic function and 
encouraging neuronal growth.  This data is consistent with Epo D regulating neuronal 
sprouting by stabilizing microtubules in a dose dependent manner and represent the 
critical first step in the pathway of investigating Epo D as a potential candidate for 
controlling axonal regeneration following injury.  Collectively, these studies pave the 
way for future investigations targeting axonal regeneration in the mature central 
nervous system following trauma.  
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5. DISCUSSION 
 
Traumatic brain injury (TBI) remains a global leading cause of death and 
disability in young people (Leibson et al., 2011, Reis et al., 2015). Moreover TBI has 
been associated with the development of chronic neurodegenerative disorders like 
Alzheimer’s disease and Parkinson’s disease (Moretti et al., 2012, Bigler, 2013, 
DeKosky et al., 2013, Esopenko and Levine, 2015, Faden and Loane, 2015, Li et al., 
2016). Currently the treatment of TBI is limited to intensive clinical care immediately 
after injury and long-term rehabilitation (Diaz-Arrastia et al., 2014, Kochanek et al., 
2015). However, there is a lack of clinically proven neuroprotective, 
neuroregenerative and therapeutic agents that can limit secondary injury and 
enhance repair. In fact in the last two decades more than 75 clinical trials have tested 
treatments for TBI, but none of the treatments studied has been proven to safely and 
effectively reverse the damage brought on by the injury (Yue et al., 2013, Diaz-
Arrastia et al., 2014, Stein, 2015). This lack of clinical translation is directly related to 
an incomplete understanding of the mechanisms activated after injury. It is assumed 
that the vast and deleterious consequences of TBI are associated to the incapacity of 
the adult brain to completely repair after an insult. Therefore, identifying the cellular 
response to injury is vital for developing effective future therapies to treat brain injury. 
Moreover, elucidating cell-type specific pathologies would not only help consolidate 
our current understating of disease mechanisms but also potentially identify novel 
therapeutic targets.  
There is evidence that suggests that the response to injury depends not only 
on the injury type but also on the neuronal cell type that might be affected. Thus this 
thesis utilized in vitro and in vivo methodological approaches, focusing on specific 
neuronal subpopulations within the neocortex, to provide novel insight into how the 
mature brain responds to injury. The central hypothesis of this thesis was that 
excitatory and inhibitory neurons respond differently to trauma. The mechanisms 
activated after injury were investigated with particular focus on axonal regenerative 
response, compensatory plasticity and their functional consequences. In order to 
address the hypothesis, this thesis investigated three aims. In Aim 1 axonal sprouting 
and dendritic remodeling were characterized following in vitro axonal transection of 
primary cortical neurons, with responses compared between excitatory and inhibitory 
neuronal populations (Chapter 2).  The functional consequence of this post-injury 
response was investigated using electrophysiological techniques.  To extend upon 
the observations of Aim 1, and investigate the susceptibility of interneurons to injury 
in vivo, as described in Aim 2 of this thesis, alterations in the inhibitory network and 
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in a specific subpopulation of interneurons were characterized following the induction 
of mild TBI using the lateral FPI model (Chapter 3). Additionally, the functional output 
of interneurons following FPI was investigated using electrophysiology. Finally, 
axonal sprouting manipulation through the administration of a microtubule-stabilizing 
drug, Epothilone D, was thoroughly investigated in Chapter 4 using an in vitro model 
of injury.  
Axons are highly vulnerable to injury as they project over long-distances and 
have a complex and highly organized structure (Meythaler et al., 2001, Johnson et 
al., 2012). After injury, axons attempt regeneration in the form of a sprouting 
response (Chuckowree and Vickers, 2003, Blizzard et al., 2011, McKillop et al., 
2016). This regeneration or reorganization after injury could lead to an adaptive 
reconnection to the original targets or to maladaptive processes in the form of 
aberrant connections that can be linked to epileptogenesis (Prince et al., 2009, Hunt 
et al., 2013). In the current thesis, Thy-1 YFP transgenic mice that express YFP in a 
subset of excitatory neurons were used to investigate cell type specific responses to 
injury. Data obtained from in vitro experiments show that mature pyramidal neurons 
attempt regeneration and sprout into the injury site indicating that the axonal 
regenerative response is an intrinsic response to injury that is neuron type-specific. 
The response of a population of GAD67-GFP positive inhibitory neurons was also 
investigated using immunocytochemical techniques.  In this population, there were 
no axonal sprouts present in the injury site. Further results presented in Chapter 2 
indicate that the initiation of the post-injury sprouting response in pyramidal neurons 
after transection injury is likely linked to an increased excitability, demonstrated by an 
increased firing frequency in these neurons. Post-injury hyperexcitability has been 
established in the past, whether it is a protective or pathogenic mechanism related to 
the development of post-traumatic epileptogenesis remains inconclusive and further 
studies at later post-injury time-points would be required to establish the  long term 
consequences of the early excitability found.  
Interestingly in vitro studies in Chapter 4 determined that the axonal sprouting 
response can be modulated by microtubule stabilization; high doses of the 
microtubule-stabilizing drug Epothilone D discouraged neuronal sprouting, while low 
doses promoted axonal growth (Brizuela et al., 2015). These findings indicate that 
Epothilone D may be a good candidate for manipulating axonal regeneration 
following injury in a dose-dependent manner, possibly preventing aberrant 
connections and hyperexcitability when administered at high doses, or stabilizing 
	   109	  
damaged microtubules to promote axonal recovery following low dose exposure. 
Whether post-injury axonal sprouting could contribute to functional recovery after 
injury remains contentious (Schwab, 2002, Lee et al., 2014, Geoffroy et al., 2015).  In 
this regard, the opposing effects of low and high doses of Epothilone D on post-injury 
sprouting could be beneficial, as encouraging axonal regeneration may be 
advantageous in one facet and then deleterious in another. Therefore a drug that 
could control neuroplasticity in a dose dependent manner could be an important 
therapeutic intervention after TBI. Further studies would be aimed to investigate the 
appropriate timing of treatment with Epothilone D to take advantage of the drug’s 
concentration dependent effects on axonal sprouting. Moreover future studies would 
need to be carried out using in vivo animal models of injury in order to determine if 
treatment with this microtubule-stabilizing drug can promote brain healing and 
functional recovery following traumatic injury to the brain.  
The neuronal response to injury is not limited to axonal regeneration.  After a 
traumatic injury to the brain neurons can respond and attempt regeneration through 
the spontaneous rearrangement of the affected network through the induction of 
structural or morphological plasticity (Macias, 2008). This thesis demonstrated cell-
type specific injury induced morphological changes using an in vitro model of injury. It 
was determined in Chapter 2 that only a specific population of interneurons, and not 
all subtypes of interneurons or pyramidal neurons, has the capacity for structural 
dendrite remodeling directed away from the injury site. Calretinin interneuron 
remodeling towards undamaged areas could be related to the loss of original 
connections and the formation of new synaptic connections. Electrophysiological 
studies in Chapter 2 point to a  possible link between dendritic remodeling of 
inhibitory neurons, axonal sprouting of excitatory neurons and hyperexcitability after 
injury given that they where found at the same time point post-injury in the same 
injured area. Although as previously discussed in Chapter 2 it is also plausible that 
the different response to injury of excitatory and inhibitory neurons found in vitro is 
related to a differential effect of diffusible factors released around the injury onto 
these specific neuronal subtypes.   
As previously stated, while maladaptive axonal sprouting of excitatory 
neurons has been previously linked to hyperexcitability (Prince and Tseng, 1993, 
Prince et al., 1997), it is plausible that decreased inhibitory input due to dendritic 
remodeling of interneurons towards undamaged areas also plays a role in the 
increased excitability found. Results in Chapter 3 further point to a decrease in 
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inhibitory input after injury related to alterations in the dendritic arbor of the same 
subpopulation of inhibitory neurons. This finding provides further powerful insight into 
the capacity of the CNS for compensatory plasticity and the change in the balance 
between excitation and inhibition that can develop as a consequence. Future studies 
would be aimed to investigate functional alterations in CR interneurons due to post-
injury dendritic remodeling by performing patch clamp recordings from these 
neurons.  
A majority of cases of TBI (approximately 70-80 percent) are mild injuries that 
involve only brief loss of consciousness (Arciniegas et al., 2005, Dewan et al., 2016). 
Although the deficits produced by mild TBI are frequently subtle, memory, affective 
and executive dysfunction can nevertheless emerge and cause substantial 
impairment and life disruption (Albrecht et al., 2016, Girgis et al., 2016). GABA is the 
main inhibitory neurotransmitter in the CNS and GABAergic interneurons play an 
important role in the synchronization of network activity. Therefore, alterations in the 
inhibitory circuit could lead to shifts in the balance between excitation and inhibition 
that may result in cognitive impairment (Almeida-Suhett et al., 2015, Drexel et al., 
2015, Smith et al., 2015, Carron et al., 2016). Using an in vivo model of injury this 
thesis demonstrated that trauma induced cortical reorganization in the form of sub-
population specific morphological changes of inhibitory neurons; a decrease in 
dendritic arbor complexity was found in Calretinin interneurons after injury. The 
vulnerability of this subpopulation of interneurons, in the form of loss or 
reorganization of dendrites, has been described in animal models of ischemia and 
epilepsy (Toth et al., 2010, Toth and Magloczky, 2014). Results presented in Chapter 
3 also demonstrated cortical changes in inhibitory input onto excitatory neurons after 
mild TBI with no overall loss of interneurons.  Calretinin interneurons are suggested 
to play a key role in the inhibitory network since they can effectively synchronize 
dendritic inhibitory interneurons. Therefore it is possible that the post-injury dendritic 
remodeling of this population of interneurons is related to a decreased inhibitory input 
onto pyramidal neurons that leads to an excitation-inhibition imbalance after mild TBI. 
Hence, targeting these inhibitory neurons after injury could potentially improve 
functional deficits found as a result of TBI.  Pharmaceutical therapeutic agents that 
directly target the inhibitory circuit have been used successfully in other diseases 
where excitability and interneuron alterations are present (Rudolph and Mohler, 
2014, Schousboe et al., 2014). However, in TBI this must be treated with caution as 
it has been demonstrated in this thesis that the response to injury is a complicated 
evolving time line of cell specific neuronal changes.  Therefore, manipulation to either 
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induce axonal regeneration with microtubule stabilizing agents, as demonstrated in 
this thesis, or potentially targeting the inhibitory system, would need to be precisely 
timed.  Future directions of the current thesis would be trialling these potential 
therapeutic interventions. 
5.1. CONCLUSION 
 
The adult brain retains the capacity to remodel and attempt to compensate for 
functional loss after injury, although it remains unclear whether all neuronal 
subpopulations have the same plastic ability. This thesis demonstrated that different 
subpopulations of neocortical interneurons respond to injury in a specific and unique 
manner different from other populations of interneurons and excitatory neurons. 
Furthermore, the findings of the thesis indicate that post-injury axonal sprouting of 
excitatory neurons and dendritic remodeling of inhibitory neurons result in potentially 
functionally inappropriate outcomes.  However, it was also demonstrated that axonal 
sprouting could be modulated by microtubule stabilization. Moreover, it was 
established that injury induces morphological changes in a subpopulation of 
interneurons and that those changes can be related to functional abnormalities after 
injury. Overall this thesis presented insight into a differential response to injury of 
excitatory and inhibitory neurons that may provide novel therapeutic targets for the 
treatment of TBI.  
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7. APPENDIX 	  
7.1 General and Cell culture solutions	  
 
 
 
0.01M PBS, pH 7.4 
 
100mL 9% NaCl (90g of NaCl (Sigma, USA) per 1L Milli-Q® water) 
 
40mL Na2HPO4 (BDH) (28.4g per 1L Milli-Q® water) 
 
10mL NaH2PO4.2H2O (Sigma) (31.2g per 1L Milli-Q® water) 
 
850mL Milli-Q® water 
 
 
0.001% poly-l-lysine 
 
450mL sterile 0.01M PBS 
 
50mL 0.01% poly-l-lysine (Sigma, USA) 
 
 
7.2 Immunocytochemistry and immunohistochemistry solutions 
 
0.3% Triton/PBS 
 
600µL Triton X (Sigma) 
 
200mL 0.01M PBS 
 
 
4% Paraformaldehyde (PFA) 
 
40g PFA (Sigma, USA) 
 
40g Sucrose (Sigma, USA) 
 
100mL 9% NaCl 
 
400mL Na2HPO4 
 
500mL NaH2PO4.2H2O 
 
Heat while stirring in a fume hood. 
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7.3 Immunoblotting solutions 
 
 
10% Sodium Dodecyl Sulfate (SDS) 
 
10g SDS (BDH, USA) 
 
Dissolve in 90mL of Milli-Q® water with gentle stirring and adjust to 100mL with 
 
Milli-Q®.  
 
 
5X Running Buffer, pH 8.3 
 
9g Tris base 
 
43.2g Glycine (Bio-Rad, USA) 
 
3g SDS 
 
Combine and add 600mL of Milli-Q® water. Combine 100mL Running  
 
Buffer with 400mL Milli-Q® water prior to use 
 
 
Transfer Buffer 
 
3.03g Tris base 
 
14.4g Glycine 
 
200mL Methanol (Sigma, USA) 
 
Make up to 1L with 800mL of Milli-Q® water. 
 
 
Tris buffered saline (TBS) 
 
4.84g Tris base 
 
58.4g NaCl 
 
1.5L Milli-Q® 
 
Adjust to pH 7.5 with 10M HCl and make up to 2L with Milli-Q® water. 
 
 
Tris buffered saline with Tween (TTBS) 
 
1.1L TBS 
 
550uL Tween-20 (Bio-Rad, USA) 
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TTBS/5% skim milk powder 
 
100mL TTBS 
 
5g skim milk powder 
 
Store at 4°C for a limited time. 
 
 
12% Separating gel 
 
3.35mL Milli-Q® water 
 
2.5mL 1.5M Tris-HCl, pH 8.8 
 
100µL 10% SDS 
 
4mL Bis/Acrylamide 
 
Add quickly immediately prior to pouring 
 
50µL 10% APS (Bio-Rad, USA) 
 
5µL TEMED (Bio-Rad, USA) 
 
Combine ingredients in the listed order and pour gel immediately. Allow to  
 
polymerization. 
  
 
4% Stacking gel 
 
6.1mL Milli-Q® water 
 
2.5mL 0.5M Tris-HCl, pH 6.8 
 
100µL 10% SDS 
 
1.33mL Bis/Acrylamide 
 
50µL 10% APS 
 
10µL TEMED 
 
